Diagnosis,Treatment code,Diagnosis code,Specialism code,Diagnosis Treatment Combination ID,Age,Case ID,label,Activity code,Producer code,Section,Specialism code.1,group,Number of executions,time:timestamp,timesincemidnight,month,weekday,hour,timesincelastevent,timesincecasestart,event_nr,open_cases
Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-06-06 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,526.0
Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-06 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,526.0
Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-06 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,526.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,5.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,7.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,3.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,6.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,8.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,10.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,4.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,9.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,13.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,15.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,8.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,14.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,14.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,16.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,9.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,15.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,15.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,17.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,10.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,16.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,18.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,20.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,11.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,19.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,19.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,21.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,12.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,20.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,23.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,14.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,22.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,21.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,27.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,22.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,28.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,23.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,23.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,29.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,24.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,31.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,378609S,BLOB,Section 4,SC86,General Lab Clinical Chemistry,10.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,32.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,3.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,3.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,4.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,5.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,3.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,4.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,4.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,6.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,5.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,6.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,8.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,7.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,7.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,9.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,8.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,9.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,11.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,5.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,10.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,10.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,12.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,11.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,11.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,13.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,6.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,12.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,12.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,14.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,7.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,13.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,16.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,18.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,17.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,17.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,19.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,18.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,20.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,22.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,13.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,21.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,24.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,2.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,25.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC375005,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,26.0,530.0
Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,15.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,24.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,30.0,530.0
maligniteit ovarium | tuba,TC603,M16,SC7,DTC493258,53.0,734,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,25.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,25.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,33.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,26.0,530.0
maligniteit cervix,TC101,M13,SC7,other,47.0,732,regular,AC386902,SRA4,Section 5,SC62,Radiology,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,27.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,34.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,28.0,530.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-07 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,35.0,530.0
Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737,regular,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC513095,57.0,735,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,533.0
Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC513095,57.0,735,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC495023,53.0,736,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC495023,53.0,736,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,533.0
Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-11 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,7.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,5.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,6.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,5.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,10.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,8.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,9.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,8.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,15.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,13.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,14.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,13.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,16.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,14.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,15.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,14.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,17.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,15.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,15.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,20.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,18.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,19.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,18.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,21.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,19.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,20.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,19.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,23.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,22.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,21.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,24.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,23.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,25.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,21.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,24.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,22.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,26.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,22.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,25.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,23.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,3.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,4.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,5.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,4.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,6.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,4.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,5.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,4.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,8.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,6.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,7.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,6.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,9.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,7.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,8.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,7.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,11.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,9.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,10.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,9.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,12.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,10.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,11.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,10.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,13.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,11.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,12.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,11.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,14.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,12.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,13.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,12.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,18.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,17.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,16.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,19.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,17.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,18.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,17.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,22.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,20.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,21.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,20.0,533.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC785237,72.0,738,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,27.0,533.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC768872,46.0,739,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,23.0,533.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,26.0,533.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,24.0,533.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC387070,SRA4,Section 5,SC62,Radiology,1.0,2006-06-13 23:00:00,1380.0,6.0,1.0,23.0,8640.0,8640.0,36.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,6.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,9.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,14.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,15.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,19.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,20.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,22.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,23.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,24.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,3.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,4.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,5.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,7.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,8.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,10.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,11.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,12.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,13.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,17.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,18.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,21.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,25.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,26.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,27.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,11520.0,11520.0,29.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,28.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-15 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,29.0,533.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,6.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,8.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,9.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,11.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,14.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,16.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,17.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,15.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,17.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,18.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,16.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,18.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,19.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,19.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,20.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,20.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,21.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370701S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,22.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370707S,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,23.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370711S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,24.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,19.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,24.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,20.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,25.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370715S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,25.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370737S,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,26.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,27.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,28.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,29.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,377121S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,29.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,22.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,30.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,30.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,23.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,32.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,32.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,4.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,4.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,5.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,6.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,4.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,5.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,6.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,7.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,5.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,7.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,7.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,9.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,8.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,8.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,10.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,9.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,10.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,10.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,12.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,12.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,11.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,13.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,13.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370424,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,14.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,12.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,14.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,15.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,13.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,15.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,16.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,17.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,22.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,18.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,23.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,21.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC372414,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,27.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,21.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,26.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,28.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC378149,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,31.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,31.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC378458,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,33.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,24.0,535.0
Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,33.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,25.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,26.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,34.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,35.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,36.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,27.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,37.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC387001,SRA1,Section 5,SC62,Radiology,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,38.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC40014,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,28.0,535.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,535.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC410100,other,Section 1,SC13,Internal Specialisms clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,39.0,535.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC513095,57.0,735,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,10080.0,10080.0,3.0,535.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,29.0,535.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,535.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,4.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC419100,other,Section 1,SC13,Internal Specialisms clinic,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,40.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC610001,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,41.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC613000,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,42.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,other,other,Section 6,SC13,other,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-18 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,11.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370480A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,51.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,52.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,53.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,54.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,57.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,379000A,other,Section 4,SC86,other,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,58.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,44.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,45.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,46.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,47.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,48.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,50.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,56.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,59.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,60.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC40014,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,43.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC613000,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,1440.0,1440.0,61.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,49.0,535.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 23:00:00,1380.0,6.0,0.0,23.0,0.0,1440.0,55.0,535.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,9.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,12.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,17.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,18.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,19.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,66.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,67.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,22.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,23.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,25.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,29.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,30.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,32.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,378609S,BLOB,Section 4,SC86,General Lab Clinical Chemistry,10.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,33.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,63.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,64.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,5.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,6.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,7.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,65.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,8.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,10.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,11.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,13.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,14.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,15.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,16.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,20.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,21.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,24.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,26.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC375005,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,27.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,31.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,68.0,534.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC386042,SRA6,Section 5,SC62,Radiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,18720.0,38.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC40014,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,62.0,534.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC613000,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,1440.0,2880.0,69.0,534.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,18720.0,37.0,534.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,10080.0,18720.0,39.0,534.0
Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744,deviant,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,11.0,2006-06-20 23:00:00,1380.0,6.0,1.0,23.0,0.0,2880.0,28.0,534.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,0.0,4320.0,72.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC386042,SRA6,Section 5,SC62,Radiology,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,0.0,4320.0,71.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC40014,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,0.0,4320.0,70.0,531.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,8640.0,20160.0,30.0,531.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC613000,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-21 23:00:00,1380.0,6.0,2.0,23.0,1440.0,4320.0,73.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,1.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,6.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,9.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,14.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,15.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,16.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,19.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,20.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,83.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,22.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,23.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,85.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,24.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,75.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,76.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,77.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,78.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,2.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,3.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,4.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,79.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,5.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,7.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,8.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,80.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,10.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,11.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,81.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,12.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,82.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,13.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,17.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,18.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,21.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,84.0,531.0
Maligne nieuwvormingen ovarium (nno),TC104,M16,SC7,DTC504958,67.0,749,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,25.0,531.0
Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,deviant,AC40014,F6NO,Section 1,SC13,Nursing ward,1.0,2006-06-22 23:00:00,1380.0,6.0,3.0,23.0,0.0,5760.0,74.0,531.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,5.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,5.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,8.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,11.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,13.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,12.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,14.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,13.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,15.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370701S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,15.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,18.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,19.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,370715S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,16.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,21.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,22.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,377121S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,18.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,23.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,24.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,3.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,4.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,1.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,2.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,3.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,4.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,6.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,6.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,7.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,7.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,9.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,8.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,10.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,9.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,11.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,10.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,12.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,16.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,17.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,14.0,532.0
Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,5760.0,17.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,20.0,532.0
maligniteit cervix,TC803,M13,SC7,DTC506733,38.0,750,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-25 23:00:00,1380.0,6.0,6.0,23.0,0.0,0.0,25.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,339988E,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,17280.0,32.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,4.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,5.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,7.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,8.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,12.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,13.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,13.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,14.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,14.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,15.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,15.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,18.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,16.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,19.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,18.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,21.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,19.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,22.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,20.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,23.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC339160,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,17280.0,31.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,3.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,4.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,5.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,6.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,6.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,7.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,8.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,9.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,9.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,10.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,10.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,11.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,11.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,12.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,16.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,17.0,536.0
Metastasen corpus maligniteit uteri (nno),TC101,M14,SC7,DTC508767,72.0,755,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,17.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,20.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,24.0,536.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,12960.0,12960.0,30.0,536.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,28800.0,40.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,17280.0,30.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,17280.0,33.0,536.0
maligniteit vulva,TC101,M11,SC7,other,67.0,751,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
maligniteit vulva,TC101,M11,SC7,other,84.0,752,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
maligniteit cervix,TC101,M13,SC7,other,40.0,754,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,1.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,17280.0,34.0,536.0
maligniteit vulva,TC101,M11,SC7,other,67.0,751,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
maligniteit vulva,TC101,M11,SC7,other,84.0,752,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
maligniteit cervix,TC101,M13,SC7,other,40.0,754,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,0.0,2.0,536.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,28800.0,41.0,536.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,0.0,28800.0,42.0,536.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,10080.0,28800.0,43.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-06-27 23:00:00,1380.0,6.0,1.0,23.0,17280.0,17280.0,35.0,536.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,339488A,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,46.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,47.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,7.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,10.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,15.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,16.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,17.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,20.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,21.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,23.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,24.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,25.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,1.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,48.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,2.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,3.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,4.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,5.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,6.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,8.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,9.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,11.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,12.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,13.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,14.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,18.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,19.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,22.0,535.0
Maligne nieuwv. corpus uteri (nno),TC101,M14,SC61,DTC785421,60.0,757,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,0.0,26.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,44.0,535.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,11520.0,2.0,535.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,11520.0,11520.0,3.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,49.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,1440.0,30240.0,50.0,535.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC7,DTC493253,78.0,731,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-06-28 23:00:00,1380.0,6.0,2.0,23.0,0.0,30240.0,45.0,535.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,339171A,other,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,1.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,40.0,535.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,2.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,39.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,41.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,36.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,37.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,38.0,535.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,3.0,535.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,0.0,4.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,42.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,0.0,20160.0,43.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-06-29 23:00:00,1380.0,6.0,3.0,23.0,2880.0,20160.0,44.0,535.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,47.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,7.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,10.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,53.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,15.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,54.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,16.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,55.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,17.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370701S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,57.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,20.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,21.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,58.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,23.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377121S,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,60.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,24.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,25.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,45.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,46.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,4.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,5.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,6.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,8.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,48.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,9.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,49.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,11.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,50.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,12.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,51.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,13.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,52.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,14.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,18.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,19.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,56.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,59.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,22.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,26.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,61.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,62.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,27.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,28.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,24480.0,63.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,29.0,536.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,other,78.0,760,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,4320.0,24480.0,64.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,30.0,536.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,other,78.0,760,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-02 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-07-03 23:00:00,1380.0,7.0,0.0,23.0,0.0,1440.0,31.0,536.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-07-03 23:00:00,1380.0,7.0,0.0,23.0,1440.0,1440.0,32.0,536.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,370828A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,376425A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC350507,LVPT,Section 4,SC88,Pathology,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,539.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,539.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,26.0,539.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC386041,SRA6,Section 5,SC62,Radiology,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,1440.0,2880.0,33.0,539.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC513095,57.0,735,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,33120.0,4.0,539.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,10080.0,23040.0,31.0,539.0
Gynaecologische tumoren,TC61,DC106,SC7,other,60.0,761,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,539.0
maligniteit endometrium,TC61,DC106,SC61,other,49.0,762,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,539.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC513095,57.0,735,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,23040.0,33120.0,5.0,539.0
Gynaecologische tumoren,TC61,DC106,SC7,other,60.0,761,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,539.0
maligniteit endometrium,TC61,DC106,SC61,other,49.0,762,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-04 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,539.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-07-05 23:00:00,1380.0,7.0,2.0,23.0,4320.0,28800.0,65.0,538.0
maligniteit cervix,TC101,M13,SC7,other,49.0,765,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-05 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,538.0
maligniteit cervix,TC101,M13,SC7,other,49.0,765,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-05 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,5.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,8.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,13.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,14.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,15.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,18.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,19.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,23.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,24.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,25.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,1.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,2.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,3.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,4.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,6.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,7.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,9.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,10.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,11.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,12.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,16.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,17.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,20.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372441,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,21.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC376406,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,22.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,26.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,27.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,28.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,1440.0,30240.0,66.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,29.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-06 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,30.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,7.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,10.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,15.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,16.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,17.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,20.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,21.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,23.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,24.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,25.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,26.0,538.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,7200.0,10080.0,34.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,4.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,5.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,6.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,8.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,9.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,11.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,12.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,13.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,14.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,18.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,19.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,22.0,538.0
maligniteit endometrium,TC103,M14,SC7,DTC516261,71.0,767,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-09 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,27.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,73.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,80.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,81.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,82.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,68.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,69.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,70.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,71.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,72.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,74.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,75.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,76.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,77.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,78.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,79.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,83.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,84.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,85.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,0.0,36000.0,67.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-10 23:00:00,1380.0,7.0,0.0,23.0,5760.0,36000.0,86.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,536.0
Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,37440.0,87.0,536.0
"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,47.0,768,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,536.0
maligniteit cervix,TC101,M13,SC7,other,41.0,769,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,536.0
"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,47.0,768,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,0.0,37440.0,88.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-11 23:00:00,1380.0,7.0,1.0,23.0,1440.0,37440.0,89.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,5.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,8.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,13.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,14.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,15.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,18.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,19.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,21.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,22.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,23.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,3.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,4.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,6.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,7.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,9.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,10.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,11.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,12.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,16.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,17.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,20.0,536.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,24.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,38880.0,90.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,38880.0,92.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,1440.0,38880.0,93.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,DRAD,Section 5,SC62,Radiology,1.0,2006-07-12 23:00:00,1380.0,7.0,2.0,23.0,0.0,38880.0,91.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,97.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,99.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,104.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,105.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,106.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,107.0,537.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,31.0,537.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,32.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,95.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,96.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,98.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,100.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,101.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,102.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,103.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,108.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,109.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,110.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,111.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,112.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC380000,SRA2,Section 5,SC62,Radiology,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,113.0,537.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,1.0,537.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,10080.0,10080.0,33.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,94.0,537.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,2.0,537.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,20160.0,20160.0,5.0,537.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,3.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,114.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,115.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,0.0,40320.0,116.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 23:00:00,1380.0,7.0,3.0,23.0,1440.0,40320.0,117.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,119.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,120.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,121.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,122.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,123.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,124.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,125.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,126.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,127.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,128.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,129.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,130.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,131.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,118.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,132.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,133.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,0.0,41760.0,134.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-14 23:00:00,1380.0,7.0,4.0,23.0,1440.0,41760.0,135.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-15 23:00:00,1380.0,7.0,5.0,23.0,0.0,43200.0,136.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-15 23:00:00,1380.0,7.0,5.0,23.0,0.0,43200.0,137.0,537.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-15 23:00:00,1380.0,7.0,5.0,23.0,1440.0,43200.0,138.0,537.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,5.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,144.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,8.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,13.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,14.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,15.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,148.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,149.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,150.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,151.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,152.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,153.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,154.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,157.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,18.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,158.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,19.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,35.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,159.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,160.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,161.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,21.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,22.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,23.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,32.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,140.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,141.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,142.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,4.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,6.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,143.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,7.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,145.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,9.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,10.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,146.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,11.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,147.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,12.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,33.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,16.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,34.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,17.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,155.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,156.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,20.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,36.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,37.0,538.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,24.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,38.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,162.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,163.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,164.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,165.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,166.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,167.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,168.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,169.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,31.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,139.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC410500,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,39.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,40.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,56160.0,41.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,0.0,44640.0,170.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,36000.0,56160.0,42.0,538.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-16 23:00:00,1380.0,7.0,6.0,23.0,1440.0,44640.0,171.0,538.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370402S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,48.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370442S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,49.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370443S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,50.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370701S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,51.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC337105,OKU1,Section 3,SC7,Operating rooms,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,44.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,45.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,46.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,47.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,52.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,53.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC378458,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,54.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,55.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,43.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,46080.0,172.0,536.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC410500,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,5760.0,25920.0,6.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,57600.0,56.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,0.0,46080.0,173.0,536.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,1440.0,57600.0,57.0,536.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-17 23:00:00,1380.0,7.0,0.0,23.0,1440.0,46080.0,174.0,536.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,61.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,178.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,26.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,30.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,31.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,378609S,BLOB,Section 4,SC86,General Lab Clinical Chemistry,10.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,32.0,534.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,534.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,534.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,59.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,60.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,176.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,177.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,62.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,179.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,63.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,180.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,64.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,181.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,2.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC375005,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,29.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,65.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,182.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,34.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,35.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,36.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,58.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,175.0,534.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,37.0,534.0
maligniteit vulva,TC101,M11,SC7,other,80.0,774,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,534.0
maligniteit vulva,TC101,M11,SC7,other,74.0,775,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,534.0
maligniteit vulva,TC101,M11,SC7,other,80.0,774,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,534.0
maligniteit vulva,TC101,M11,SC7,other,74.0,775,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,534.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,38.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,59040.0,66.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,47520.0,183.0,534.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,1440.0,59040.0,67.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,1440.0,47520.0,184.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,2.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,27.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,28.0,534.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,2.0,2006-07-18 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,33.0,534.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,6.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370480A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,11.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,12.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,13.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,14.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,15.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,16.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,17.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,18.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC350507,LVPT,Section 4,SC88,Pathology,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,3.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,4.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,5.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,7.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,8.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,9.0,532.0
"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,10.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,60480.0,68.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,48960.0,185.0,532.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,14400.0,24480.0,35.0,532.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,36.0,779,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,532.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,36.0,779,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,60480.0,69.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,0.0,48960.0,186.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,1440.0,60480.0,70.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-19 23:00:00,1380.0,7.0,2.0,23.0,1440.0,48960.0,187.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,8.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,5.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,74.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,11.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,8.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,16.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,13.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,17.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,14.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,18.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,15.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,78.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,21.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,18.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,79.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,22.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,19.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,376425A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,24.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,25.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,21.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,26.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,22.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,72.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,73.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,4.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,5.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,6.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,1.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,2.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,3.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,7.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,4.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,9.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,6.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,10.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,7.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,75.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,12.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,9.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,13.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,10.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,76.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,14.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,11.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,77.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,15.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,12.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,19.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,16.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,20.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,17.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,23.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,20.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,10080.0,27.0,532.0
Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,0.0,23.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,80.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,10080.0,10080.0,28.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,71.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,50400.0,188.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,61920.0,81.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,0.0,50400.0,189.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,1440.0,61920.0,82.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-20 23:00:00,1380.0,7.0,3.0,23.0,1440.0,50400.0,190.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,0.0,63360.0,83.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,0.0,51840.0,191.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,0.0,63360.0,84.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,0.0,51840.0,192.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,1440.0,63360.0,85.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-21 23:00:00,1380.0,7.0,4.0,23.0,1440.0,51840.0,193.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,90.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,91.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,87.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,88.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,89.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,92.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,93.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,86.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,53280.0,194.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,64800.0,94.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,0.0,53280.0,195.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,1440.0,64800.0,95.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-22 23:00:00,1380.0,7.0,5.0,23.0,1440.0,53280.0,196.0,532.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,7.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,201.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,10.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,206.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,15.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,207.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,208.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,17.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,210.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,23.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,211.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,24.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,213.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,26.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,214.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,27.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,198.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,199.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,4.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,5.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,6.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,8.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,200.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,9.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,202.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,11.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,203.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,12.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,204.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,13.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,205.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,14.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,18.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,19.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,20.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,21.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,209.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,22.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,212.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,25.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,28.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,215.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,66240.0,96.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,197.0,533.0
Adenoca: corpus uteri st IIb,TC713,M14,SC61,DTC787877,70.0,782,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,533.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,66240.0,97.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,0.0,54720.0,216.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,1440.0,66240.0,98.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-23 23:00:00,1380.0,7.0,6.0,23.0,1440.0,54720.0,217.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,0.0,67680.0,99.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,0.0,56160.0,218.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,0.0,67680.0,100.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,0.0,56160.0,219.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,1440.0,67680.0,101.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-24 23:00:00,1380.0,7.0,0.0,23.0,1440.0,56160.0,220.0,533.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,14.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,15.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,19.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,22.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,23.0,532.0
Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,10080.0,10080.0,39.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,1.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,2.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,3.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,4.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,5.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,6.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,7.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,8.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,9.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,10.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,11.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,12.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,13.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,16.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,17.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,18.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,20.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,21.0,532.0
Plav.celcarc. vulva: st II,TC813,M11,SC7,DTC527973,65.0,783,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,24.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,25.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,26.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,27.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,69120.0,102.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,57600.0,221.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,28.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,10080.0,10080.0,7.0,532.0
Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,8640.0,33120.0,36.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,0.0,29.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,69120.0,103.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,0.0,57600.0,222.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,1440.0,69120.0,104.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-25 23:00:00,1380.0,7.0,1.0,23.0,1440.0,57600.0,223.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,37.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,12.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,226.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,227.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,228.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,17.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,18.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,19.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,229.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,230.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,20.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,25.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,26.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,27.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,231.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,232.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,32.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,379000A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,37.0,533.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,1440.0,30.0,533.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,1440.0,1440.0,31.0,533.0
maligniteit cervix,TC101,M13,SC7,other,35.0,787,regular,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,225.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,33.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,34.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,35.0,533.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,11520.0,8.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,3.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,4.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,5.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,6.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,7.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,8.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,9.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,10.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,36.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,11.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,38.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,13.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,39.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,14.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,40.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,15.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,41.0,533.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,11520.0,9.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,21.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,22.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,42.0,533.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,11520.0,10.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,23.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,24.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,43.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,28.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,29.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,30.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,31.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,33.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,34.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,44.0,533.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,11520.0,11.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,35.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,36.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,233.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,45.0,533.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,1440.0,11520.0,12.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,38.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,39.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,40.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,70560.0,105.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,224.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,32.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,533.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,1.0,533.0
maligniteit cervix,TC101,M13,SC7,other,35.0,787,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,533.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,2.0,533.0
maligniteit cervix,TC101,M13,SC7,other,35.0,787,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,3.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,54720.0,46.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,41.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,70560.0,106.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,59040.0,234.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,31680.0,54720.0,47.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,42.0,533.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,1440.0,70560.0,107.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,1440.0,59040.0,235.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,43.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,44.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,45.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,46.0,533.0
maligniteit vulva,TC103,M11,SC7,DTC528994,67.0,785,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-26 23:00:00,1380.0,7.0,2.0,23.0,0.0,0.0,47.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,239.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370402S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,54.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370402S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,55.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370402S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,56.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,241.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370426S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,59.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370442S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,60.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370442S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,61.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370442S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,62.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370443S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,63.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370443S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,64.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,247.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,248.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370701S,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,65.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370701S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,66.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,249.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,376482S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,71.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,376482S,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,72.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC337451,OKU1,Section 3,SC7,Operating rooms,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,49.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,50.0,532.0
maligniteit vulva,TC101,M11,SC7,other,67.0,751,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,43200.0,3.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,237.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,238.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,51.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,52.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,53.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,240.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,242.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,243.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370424,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,57.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,58.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,244.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,245.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC372414,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,67.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,68.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,69.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,70.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,73.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378458,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,74.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,250.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,75.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,76.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,77.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,72000.0,108.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,236.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,48.0,532.0
maligniteit vulva,TC101,M11,SC7,other,67.0,751,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,43200.0,43200.0,4.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,72000.0,109.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,251.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,56160.0,78.0,532.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,1440.0,72000.0,110.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,1440.0,60480.0,252.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,1440.0,56160.0,79.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-27 23:00:00,1380.0,7.0,3.0,23.0,0.0,60480.0,246.0,532.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,6.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,10.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,11.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,17.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,18.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,3.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,4.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,5.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,7.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,8.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,9.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,12.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,13.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,14.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,15.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,16.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,19.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,61920.0,253.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,57600.0,80.0,533.0
Maligne neoplasma cervix uteri,TC81,M13,SC61,DTC534329,50.0,788,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,0.0,1.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,0.0,61920.0,254.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,1440.0,57600.0,81.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-28 23:00:00,1380.0,7.0,4.0,23.0,1440.0,61920.0,255.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-29 23:00:00,1380.0,7.0,5.0,23.0,0.0,59040.0,82.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-29 23:00:00,1380.0,7.0,5.0,23.0,1440.0,59040.0,83.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,5.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,60480.0,86.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,8.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,13.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,14.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,15.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,18.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,19.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,21.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,22.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,23.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,60480.0,85.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,1.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,2.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,3.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,4.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,6.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,7.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,9.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,10.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,11.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,12.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,16.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,17.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,20.0,533.0
maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,0.0,24.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,60480.0,87.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,0.0,60480.0,84.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-30 23:00:00,1380.0,7.0,6.0,23.0,1440.0,60480.0,88.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,258.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,263.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,264.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,256.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,257.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,259.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,260.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,261.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,262.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,66240.0,265.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,0.0,61920.0,89.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,4320.0,66240.0,266.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-07-31 23:00:00,1380.0,7.0,0.0,23.0,1440.0,61920.0,90.0,533.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,37.0,534.0
other,TC101,M15,SC7,other,78.0,790,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,534.0
other,TC101,M15,SC7,other,78.0,790,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,33.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,34.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,35.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,36.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,38.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,39.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,40.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,41.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,42.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,43.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,44.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC389190,SRA6,Section 5,SC62,Radiology,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,45.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,63360.0,91.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,32.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,67680.0,267.0,534.0
other,TC101,M15,SC7,other,78.0,790,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,3.0,534.0
other,TC101,M15,SC7,other,78.0,790,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,4.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,0.0,10080.0,46.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,1440.0,63360.0,92.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,8640.0,10080.0,47.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-01 23:00:00,1380.0,8.0,1.0,23.0,1440.0,67680.0,268.0,534.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,1.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,11520.0,49.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,16.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,6.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,19.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,9.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,24.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,14.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,25.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,15.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,26.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,16.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,27.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,19.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,28.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,20.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,30.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,22.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,31.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,23.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,32.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,24.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,11520.0,50.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,11520.0,51.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,13.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,14.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,2.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,3.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,4.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,15.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,5.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,17.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,7.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,18.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,8.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,20.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,10.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,21.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,11.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,22.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,12.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,23.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,13.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,17.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,18.0,532.0
Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,21600.0,29.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,21.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,25.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,26.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,27.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,69120.0,269.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,64800.0,93.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,11520.0,48.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,28.0,532.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,10080.0,10080.0,3.0,532.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,29.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,69120.0,270.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,0.0,69120.0,271.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,1440.0,64800.0,94.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,1440.0,11520.0,52.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,1440.0,69120.0,272.0,532.0
other,TC101,M15,SC7,other,78.0,790,regular,other,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 23:00:00,1380.0,8.0,2.0,23.0,1440.0,1440.0,5.0,532.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,6.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,9.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,14.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,15.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,16.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,19.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,20.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,22.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,23.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,24.0,533.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,1440.0,30.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,1.0,533.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,1440.0,1440.0,31.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,2.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,3.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,4.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,5.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,7.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,8.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,10.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,11.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,12.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,13.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,17.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,18.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,21.0,533.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,25.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,273.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,66240.0,95.0,533.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,12960.0,53.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,274.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,1440.0,66240.0,96.0,533.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,1440.0,12960.0,54.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-03 23:00:00,1380.0,8.0,3.0,23.0,1440.0,70560.0,275.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,0.0,67680.0,98.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,0.0,67680.0,99.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,0.0,67680.0,100.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,0.0,67680.0,101.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,0.0,67680.0,97.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-04 23:00:00,1380.0,8.0,4.0,23.0,1440.0,67680.0,102.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-05 23:00:00,1380.0,8.0,5.0,23.0,0.0,69120.0,103.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-05 23:00:00,1380.0,8.0,5.0,23.0,1440.0,69120.0,104.0,533.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,7.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,278.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,10.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,15.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,16.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,17.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,283.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,20.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,284.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,21.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,23.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,24.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,276.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,277.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,3.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,4.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,5.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,6.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,8.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,9.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,279.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,11.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,12.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,280.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,13.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,281.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,14.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,18.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,19.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,282.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,22.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,25.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,285.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,26.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,27.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,28.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,70560.0,105.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,29.0,534.0
Adenoca: corpus uteri st Ia,TC101,M14,SC7,other,77.0,794,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,4320.0,74880.0,286.0,534.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,20160.0,20160.0,4.0,534.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,30.0,534.0
Adenoca: corpus uteri st Ia,TC101,M14,SC7,other,77.0,794,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-06 23:00:00,1380.0,8.0,6.0,23.0,1440.0,70560.0,106.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-08-07 23:00:00,1380.0,8.0,0.0,23.0,0.0,76320.0,287.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-07 23:00:00,1380.0,8.0,0.0,23.0,0.0,76320.0,288.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-07 23:00:00,1380.0,8.0,0.0,23.0,1440.0,76320.0,289.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-07 23:00:00,1380.0,8.0,0.0,23.0,0.0,72000.0,107.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-07 23:00:00,1380.0,8.0,0.0,23.0,1440.0,72000.0,108.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-08 23:00:00,1380.0,8.0,1.0,23.0,0.0,73440.0,109.0,533.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-08 23:00:00,1380.0,8.0,1.0,23.0,0.0,8640.0,32.0,533.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-08 23:00:00,1380.0,8.0,1.0,23.0,7200.0,8640.0,33.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-08 23:00:00,1380.0,8.0,1.0,23.0,1440.0,73440.0,110.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,30.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,31.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,32.0,533.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC350507,LVPT,Section 4,SC88,Pathology,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,1.0,533.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,4320.0,31.0,533.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,2.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,291.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,33.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,292.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,34.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,293.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,35.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,294.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,295.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,296.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,36.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,297.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,37.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,298.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,299.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,300.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,301.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,302.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,290.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,74880.0,111.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,29.0,533.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,3.0,533.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,4320.0,4320.0,32.0,533.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,4.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,303.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,38.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,304.0,533.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,1440.0,74880.0,112.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,38880.0,39.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,305.0,533.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,28800.0,38880.0,40.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,0.0,79200.0,306.0,533.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-09 23:00:00,1380.0,8.0,2.0,23.0,2880.0,79200.0,307.0,533.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,11.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,14.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,19.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,20.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,21.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,22.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,23.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,24.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,28.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,29.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,31.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,32.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,35.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC337451,OKU1,Section 3,SC7,Operating rooms,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,40320.0,42.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,40320.0,43.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,2.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,40320.0,44.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,3.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,4.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,5.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,6.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,7.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,8.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,9.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,10.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,12.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,13.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,15.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,16.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,17.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,18.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,25.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,26.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,27.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,30.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,33.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,34.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,36.0,534.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,2880.0,11520.0,34.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,80640.0,308.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,76320.0,113.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,40320.0,41.0,534.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC537940,45.0,796,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,1.0,534.0
maligniteit vulva,TC101,M11,SC7,other,67.0,751,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,20160.0,63360.0,5.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,80640.0,309.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,1440.0,76320.0,114.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,0.0,40320.0,45.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,1440.0,80640.0,310.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-10 23:00:00,1380.0,8.0,3.0,23.0,1440.0,40320.0,46.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-11 23:00:00,1380.0,8.0,4.0,23.0,0.0,77760.0,115.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-11 23:00:00,1380.0,8.0,4.0,23.0,0.0,41760.0,47.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-11 23:00:00,1380.0,8.0,4.0,23.0,1440.0,77760.0,116.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-11 23:00:00,1380.0,8.0,4.0,23.0,0.0,41760.0,48.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-11 23:00:00,1380.0,8.0,4.0,23.0,1440.0,41760.0,49.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-12 23:00:00,1380.0,8.0,5.0,23.0,0.0,79200.0,117.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-12 23:00:00,1380.0,8.0,5.0,23.0,0.0,43200.0,50.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-12 23:00:00,1380.0,8.0,5.0,23.0,1440.0,79200.0,118.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-12 23:00:00,1380.0,8.0,5.0,23.0,0.0,43200.0,51.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-12 23:00:00,1380.0,8.0,5.0,23.0,1440.0,43200.0,52.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,56.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,57.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,58.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,55.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,63.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,70.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,54.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,59.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,60.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,61.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,62.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,64.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,65.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,66.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,67.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,68.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,56.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,69.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,71.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,57.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,72.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,80640.0,119.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,53.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,55.0,534.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,27360.0,73.0,534.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,1440.0,80640.0,120.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,0.0,44640.0,58.0,534.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,14400.0,27360.0,74.0,534.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-13 23:00:00,1380.0,8.0,6.0,23.0,1440.0,44640.0,59.0,534.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,314.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,81.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,319.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,320.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,84.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,85.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC337452,OKU1,Section 3,SC7,Operating rooms,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,76.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,77.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,78.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,311.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,312.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,79.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,313.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,80.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,315.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,316.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,82.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,317.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,83.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,318.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,86.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,86400.0,321.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,87.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,82080.0,121.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,46080.0,60.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,28800.0,75.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,5760.0,86400.0,322.0,532.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,1440.0,82080.0,122.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,0.0,46080.0,61.0,532.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,1440.0,28800.0,88.0,532.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-14 23:00:00,1380.0,8.0,0.0,23.0,1440.0,46080.0,62.0,532.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,87840.0,323.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,47520.0,63.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,30240.0,89.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,87840.0,324.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,87840.0,325.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,0.0,47520.0,64.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,1440.0,30240.0,90.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,1440.0,87840.0,326.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-15 23:00:00,1380.0,8.0,1.0,23.0,1440.0,47520.0,65.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,39.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,45.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,46.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,35.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,36.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,37.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,38.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,40.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,41.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,42.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,43.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,44.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,47.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,48.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,89280.0,327.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,34.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,48960.0,66.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,31680.0,91.0,530.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,1.0,530.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,2.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,49.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,89280.0,328.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,59040.0,50.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,0.0,48960.0,67.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,1440.0,31680.0,92.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,1440.0,89280.0,329.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,48960.0,59040.0,51.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,1440.0,48960.0,68.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,other,SRA5,Section 5,SC62,Radiology,1.0,2006-08-16 23:00:00,1380.0,8.0,2.0,23.0,10080.0,10080.0,5.0,530.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,339171A,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,9.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,67.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,68.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,69.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,70.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,63.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,64.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,65.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,66.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,93.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,94.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,95.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,96.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,97.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,98.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,99.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,100.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC337105,OKU1,Section 3,SC7,Operating rooms,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,53.0,530.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC356132,LVPT,Section 4,SC88,Pathology,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,10.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,54.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,55.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,56.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,57.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,58.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,59.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,60.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,61.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,62.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,71.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,72.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,73.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,74.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,75.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,76.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,77.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,78.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,79.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,80.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,81.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,82.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,83.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,84.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,85.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,86.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,87.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,88.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,89.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,90.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,91.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,92.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,101.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,102.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,103.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,104.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,105.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,106.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,107.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,108.0,530.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,11520.0,15840.0,33.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,52.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,33120.0,93.0,530.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,7.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,11520.0,6.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,1440.0,11520.0,7.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,60480.0,109.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,1440.0,33120.0,94.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,1440.0,60480.0,110.0,530.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,44640.0,70560.0,11.0,530.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,other,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-08-17 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,8.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-18 23:00:00,1380.0,8.0,4.0,23.0,0.0,61920.0,111.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-18 23:00:00,1380.0,8.0,4.0,23.0,0.0,34560.0,95.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-18 23:00:00,1380.0,8.0,4.0,23.0,0.0,61920.0,112.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-18 23:00:00,1380.0,8.0,4.0,23.0,1440.0,34560.0,96.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-18 23:00:00,1380.0,8.0,4.0,23.0,1440.0,61920.0,113.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-19 23:00:00,1380.0,8.0,5.0,23.0,0.0,63360.0,114.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-19 23:00:00,1380.0,8.0,5.0,23.0,0.0,36000.0,97.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-19 23:00:00,1380.0,8.0,5.0,23.0,0.0,63360.0,115.0,530.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-19 23:00:00,1380.0,8.0,5.0,23.0,1440.0,36000.0,98.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-19 23:00:00,1380.0,8.0,5.0,23.0,1440.0,63360.0,116.0,530.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,5.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,333.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,120.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,8.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,13.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,14.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,15.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,338.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,19.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,339.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,20.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,22.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,23.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,24.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,331.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,332.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,118.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,119.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,3.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,4.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,6.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,7.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,334.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,121.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,9.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,10.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,335.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,122.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,11.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,336.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,123.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,12.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,16.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,17.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,337.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,18.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,21.0,531.0
maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,25.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,340.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,124.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,330.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,117.0,531.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,37440.0,99.0,531.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,90720.0,123.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,95040.0,341.0,531.0
maligniteit endometrium,TC101,M14,SC7,other,74.0,799,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,531.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,8640.0,90720.0,124.0,531.0
maligniteit endometrium,TC101,M14,SC7,other,74.0,799,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,5760.0,95040.0,342.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,0.0,64800.0,125.0,531.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,1440.0,37440.0,100.0,531.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-20 23:00:00,1380.0,8.0,6.0,23.0,1440.0,64800.0,126.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,344.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,346.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,347.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,348.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,349.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,350.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,351.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,17280.0,8.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,345.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,352.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC380077,SRA4,Section 5,SC62,Radiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,17280.0,9.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,353.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,354.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,343.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,66240.0,127.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,96480.0,355.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,0.0,66240.0,128.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,1440.0,96480.0,356.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,1440.0,66240.0,129.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,other,SRA4,Section 5,SC62,Radiology,1.0,2006-08-21 23:00:00,1380.0,8.0,0.0,23.0,5760.0,17280.0,10.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,5.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,8.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,13.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,14.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,15.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,359.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,360.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,361.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,362.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,363.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,364.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,18.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,19.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,365.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,366.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,3.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,21.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,22.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,23.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,358.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,3.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,6.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,7.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,9.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,10.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,11.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,12.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,16.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,17.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,20.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,24.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,367.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,25.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,26.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,357.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,67680.0,130.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,27.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,5.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,28.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,6.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,97920.0,368.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,0.0,67680.0,131.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,1440.0,97920.0,369.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-22 23:00:00,1380.0,8.0,1.0,23.0,1440.0,67680.0,132.0,530.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,4.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,370828A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,5.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,1.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,2.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,3.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,6.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,7.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,1.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,110880.0,111.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,69120.0,133.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,2.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,38880.0,110880.0,112.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,8.0,529.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,2880.0,20160.0,11.0,529.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,10080.0,10080.0,3.0,529.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,9.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,0.0,3.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,0.0,69120.0,134.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-23 23:00:00,1380.0,8.0,2.0,23.0,1440.0,69120.0,135.0,529.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,1.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,8.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,11.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,16.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,17.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,18.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,21.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,22.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,24.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,25.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,2880.0,29.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,2880.0,2880.0,30.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,3.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,4.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,5.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,6.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,7.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,9.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,10.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,12.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,13.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,14.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,15.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,19.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,20.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,23.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,26.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,27.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,28.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,136.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,29.0,530.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,30.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,0.0,70560.0,137.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-24 23:00:00,1380.0,8.0,3.0,23.0,1440.0,70560.0,138.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,140.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,141.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,142.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,143.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,139.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,0.0,72000.0,144.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-25 23:00:00,1380.0,8.0,4.0,23.0,1440.0,72000.0,145.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-26 23:00:00,1380.0,8.0,5.0,23.0,0.0,73440.0,146.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-26 23:00:00,1380.0,8.0,5.0,23.0,0.0,73440.0,147.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-26 23:00:00,1380.0,8.0,5.0,23.0,1440.0,73440.0,148.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,5.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,8.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,13.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,14.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,15.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,18.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,19.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,21.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,22.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,23.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,3.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,6.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,7.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,9.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,10.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,11.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,12.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,16.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,17.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,20.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,24.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,25.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,26.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,27.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,149.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,28.0,530.0
maligniteit cervix,TC101,M13,SC7,other,40.0,806,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,1.0,530.0
maligniteit cervix,TC101,M13,SC7,other,40.0,806,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,0.0,29.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,0.0,74880.0,150.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-27 23:00:00,1380.0,8.0,6.0,23.0,1440.0,74880.0,151.0,530.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-08-28 23:00:00,1380.0,8.0,0.0,23.0,25920.0,37440.0,35.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-28 23:00:00,1380.0,8.0,0.0,23.0,0.0,76320.0,152.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-28 23:00:00,1380.0,8.0,0.0,23.0,0.0,76320.0,153.0,530.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-08-28 23:00:00,1380.0,8.0,0.0,23.0,1440.0,76320.0,154.0,530.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,6.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,7.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,9.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,10.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,14.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,15.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,15.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,16.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,16.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,17.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,19.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,20.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,20.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,21.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,22.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,23.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,23.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,24.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,24.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,25.0,531.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,8640.0,4.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,531.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,8640.0,8640.0,5.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,3.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,4.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,3.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,4.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,5.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,5.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,6.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,7.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,8.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,8.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,9.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,10.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,11.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,11.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,12.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,12.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,13.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,13.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,14.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,17.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,18.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,18.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,19.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,21.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,22.0,531.0
Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,25.0,531.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,26.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,7200.0,10080.0,31.0,531.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,12960.0,103680.0,125.0,531.0
maligniteit endometrium,TC61,DC106,SC61,other,45.0,808,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,1.0,531.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,8640.0,28800.0,12.0,531.0
maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,7200.0,7200.0,31.0,531.0
maligniteit endometrium,TC61,DC106,SC61,other,45.0,808,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-29 23:00:00,1380.0,8.0,1.0,23.0,0.0,0.0,2.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,371.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,372.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,373.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,374.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,375.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,376.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,377.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,378.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,379.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,380.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,109440.0,370.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,11520.0,109440.0,381.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,0.0,30240.0,13.0,530.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,1440.0,30240.0,14.0,530.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-30 23:00:00,1380.0,8.0,2.0,23.0,1440.0,10080.0,6.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-31 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,1.0,531.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-08-31 23:00:00,1380.0,8.0,3.0,23.0,5760.0,5760.0,30.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-31 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,2.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-31 23:00:00,1380.0,8.0,3.0,23.0,0.0,0.0,3.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,35.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,36.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,37.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,339988E,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,17280.0,34.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,376487.0,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,25.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,26.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,29.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,38.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,39.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,40.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC372439,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC378431,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,27.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,28.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,41.0,531.0
Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,25.0,531.0
Maligne neoplasma adnexa uteri,TC3101,DC839,SC7,DTC551837,66.0,814,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,30.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,42.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,34.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,17280.0,32.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,17280.0,35.0,531.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,17280.0,36.0,531.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,43.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,44.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,24480.0,40320.0,45.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,7200.0,17280.0,37.0,531.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,other,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-09-03 23:00:00,1380.0,9.0,6.0,23.0,0.0,17280.0,33.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,386.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,7.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,390.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,391.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,393.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,394.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,379000A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,396.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC337440,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,41760.0,47.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,41760.0,48.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,41760.0,49.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,382.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,383.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,384.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,4.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,5.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,6.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,385.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,387.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,8.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,388.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,9.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,389.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,10.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,11.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,12.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,392.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,395.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,5760.0,13.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,116640.0,397.0,531.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,5760.0,5760.0,14.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,41760.0,46.0,531.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,7200.0,116640.0,398.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,0.0,41760.0,50.0,531.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-04 23:00:00,1380.0,9.0,0.0,23.0,1440.0,41760.0,51.0,531.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,32.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,33.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,34.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,35.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,36.0,528.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,48960.0,36.0,528.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,48960.0,37.0,528.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,48960.0,38.0,528.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,11520.0,48960.0,39.0,528.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,43200.0,52.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,31.0,528.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC101,M16,SC7,other,32.0,815,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,1.0,528.0
maligniteit cervix,TC101,M13,SC7,other,47.0,732,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,129600.0,2.0,528.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,1440.0,118080.0,399.0,528.0
maligniteit cervix,TC101,M13,SC7,other,47.0,732,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,129600.0,129600.0,3.0,528.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC101,M16,SC7,other,32.0,815,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,2.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,12960.0,37.0,528.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,0.0,43200.0,53.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,7200.0,12960.0,38.0,528.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-05 23:00:00,1380.0,9.0,1.0,23.0,1440.0,43200.0,54.0,528.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,41.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,59.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,60.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,56.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,57.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,58.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,61.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,62.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,55.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,39.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,42.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,-1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,43.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410500,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,44.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC413461,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,45.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,46.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,44640.0,63.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,1440.0,14400.0,47.0,526.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,1440.0,44640.0,64.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-06 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,40.0,526.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,7.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,12.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,13.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,14.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,15.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,16.0,527.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,0.0,1.0,527.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,0.0,2.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,3.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,4.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,5.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,6.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,8.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,9.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,10.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,5760.0,11.0,527.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,5760.0,5760.0,17.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,46080.0,65.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,5760.0,23040.0,38.0,527.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,0.0,3.0,527.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,0.0,4.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,0.0,46080.0,66.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-07 23:00:00,1380.0,9.0,3.0,23.0,1440.0,46080.0,67.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-08 23:00:00,1380.0,9.0,4.0,23.0,0.0,47520.0,68.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-08 23:00:00,1380.0,9.0,4.0,23.0,0.0,47520.0,69.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-08 23:00:00,1380.0,9.0,4.0,23.0,1440.0,47520.0,70.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,48960.0,71.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,15.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,16.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,17.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,18.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,19.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,20.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,48960.0,72.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,21.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,0.0,12960.0,22.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,7200.0,12960.0,23.0,527.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-09 23:00:00,1380.0,9.0,5.0,23.0,1440.0,48960.0,73.0,527.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,337190C,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,27.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,29.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,30.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,31.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,32.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,33.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,34.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,35.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,36.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,529.0
Mucineus adenoca. ovarium st IIc,TC613,M16,SC7,DTC556280,48.0,819,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,25.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,37.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,38.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,25.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,26.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,27.0,529.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390001,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,46080.0,15.0,529.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,120960.0,126.0,529.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,46080.0,16.0,529.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,17280.0,120960.0,127.0,529.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,46080.0,17.0,529.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,15840.0,46080.0,18.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,50400.0,74.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,24.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,25.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,26.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,28.0,529.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,29.0,529.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,529.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,50400.0,75.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,39.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,40.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,1440.0,14400.0,41.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,1440.0,50400.0,76.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-10 23:00:00,1380.0,9.0,6.0,23.0,0.0,14400.0,28.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,400.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,401.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,402.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,403.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,404.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,405.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC386002,DRAD,Section 5,SC62,Radiology,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,406.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC388170,DRAD,Section 5,SC62,Radiology,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,126720.0,407.0,529.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,5760.0,11520.0,18.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,51840.0,77.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,15840.0,42.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,15840.0,43.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,15840.0,44.0,529.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,8640.0,126720.0,408.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,51840.0,78.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,15840.0,45.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,0.0,15840.0,46.0,529.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,-1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,1440.0,15840.0,47.0,529.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-11 23:00:00,1380.0,9.0,0.0,23.0,1440.0,51840.0,79.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,5.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,43.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,8.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,13.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,14.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,15.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,18.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,19.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,49.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,21.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,22.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,23.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,40.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,41.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,42.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,1.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,2.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,3.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,4.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,6.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,7.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,44.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,9.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,10.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,45.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,11.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,46.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,12.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,47.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,16.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,48.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,17.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,20.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,50.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,51.0,529.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC558333,42.0,820,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,24.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,52.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,39.0,529.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,7200.0,7200.0,5.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,53.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,0.0,30240.0,54.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-12 23:00:00,1380.0,9.0,1.0,23.0,7200.0,30240.0,55.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,63.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,62.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,71.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,72.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,59.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,60.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,61.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,64.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,65.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,66.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,67.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,68.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,69.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,70.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,73.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,74.0,528.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,4320.0,4320.0,5.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,56.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,75.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,1440.0,31680.0,76.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,57.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-13 23:00:00,1380.0,9.0,2.0,23.0,0.0,31680.0,58.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,0.0,33120.0,79.0,528.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,5760.0,5760.0,30.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,0.0,33120.0,78.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,0.0,33120.0,80.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,0.0,33120.0,77.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,0.0,33120.0,81.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-14 23:00:00,1380.0,9.0,3.0,23.0,1440.0,33120.0,82.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-15 23:00:00,1380.0,9.0,4.0,23.0,0.0,34560.0,83.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-15 23:00:00,1380.0,9.0,4.0,23.0,0.0,34560.0,84.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-15 23:00:00,1380.0,9.0,4.0,23.0,1440.0,34560.0,85.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-16 23:00:00,1380.0,9.0,5.0,23.0,0.0,36000.0,86.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-16 23:00:00,1380.0,9.0,5.0,23.0,0.0,36000.0,87.0,528.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-16 23:00:00,1380.0,9.0,5.0,23.0,1440.0,36000.0,88.0,528.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,12.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,14.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,15.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,18.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,19.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,22.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,23.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,8.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,9.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,10.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,3.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,5.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,4.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,6.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,11.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,8.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,7.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,13.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,9.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,10.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,14.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,11.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,15.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,13.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,12.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,16.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,16.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,17.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,18.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,17.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,21.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,20.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,19.0,529.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC785814,80.0,821,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,25.0,529.0
Adenoca: corpus uteri st IIIb,TC101,M14,SC61,DTC785694,73.0,822,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,24.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,37440.0,89.0,529.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,36000.0,7.0,529.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,1.0,529.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,0.0,2.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,0.0,37440.0,90.0,529.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-17 23:00:00,1380.0,9.0,6.0,23.0,1440.0,37440.0,91.0,529.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,5.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,8.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,14.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,15.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,16.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,19.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,20.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,21.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,23.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,24.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,409.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,3.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,410.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,6.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,411.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,7.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,412.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,9.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,10.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370437,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,11.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,413.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,12.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,414.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,13.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,17.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,18.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,22.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372441,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,415.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,25.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,26.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,136800.0,416.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,27.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC380000,SRA4,Section 5,SC62,Radiology,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,10080.0,136800.0,417.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,28.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,38880.0,92.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,29.0,530.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,10080.0,21600.0,19.0,530.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,30.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,0.0,38880.0,93.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-18 23:00:00,1380.0,9.0,0.0,23.0,1440.0,38880.0,94.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,48.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,427.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,53.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,8.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,430.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,56.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,11.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,436.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,61.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,16.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,437.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,62.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,17.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,438.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,63.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,18.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,439.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,440.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,441.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,442.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,444.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,66.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,21.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,445.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,67.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,22.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,448.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,69.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,24.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,70.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,25.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,449.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,71.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,26.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,452.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,72.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,27.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,2.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,1.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,3.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,419.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,420.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,421.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,422.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,423.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,424.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,49.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,50.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,51.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,5.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,6.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,425.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,426.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,52.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,7.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,428.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,54.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,9.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,429.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,55.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,10.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,431.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,432.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,57.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,12.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,433.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,58.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,13.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,434.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,59.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,14.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,435.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,60.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,15.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,64.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,19.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,65.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,20.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,443.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,446.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,68.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,23.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,450.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,451.0,530.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,27360.0,73.0,530.0
Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,28.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,453.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,454.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,455.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,456.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,2.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,418.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,40320.0,95.0,530.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,18720.0,33120.0,48.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,3.0,530.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,4.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,459.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,460.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,40320.0,96.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,1440.0,138240.0,461.0,530.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,1440.0,40320.0,97.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,447.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,457.0,530.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2006-09-19 23:00:00,1380.0,9.0,1.0,23.0,0.0,138240.0,458.0,530.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,41.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,43.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,40.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,99.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,32.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,100.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,33.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,34.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,42.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,101.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,35.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,44.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,102.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,36.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,-1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,45.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,70560.0,46.0,527.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,21600.0,70560.0,47.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,139680.0,462.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,98.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,31.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,103.0,527.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,48960.0,119520.0,12.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,37.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,139680.0,464.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,41760.0,104.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,14400.0,38.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,1440.0,139680.0,465.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,1440.0,41760.0,105.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,8640.0,14400.0,39.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,other,Section 1,SC13,other,1.0,2006-09-20 23:00:00,1380.0,9.0,2.0,23.0,0.0,139680.0,463.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,339488A,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,42.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,43.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,470.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,9.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,473.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,12.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,479.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,17.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,480.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,18.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,481.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,19.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,108.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,109.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,483.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,22.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,484.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,23.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,487.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,25.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,489.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,26.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC339160,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,41.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,44.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,45.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,467.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,468.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,107.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,5.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,6.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,7.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,469.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,8.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,471.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,10.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,472.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,11.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,474.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,475.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,13.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,476.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,14.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,477.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,15.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,478.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,16.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,20.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,21.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,482.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,485.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,24.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,488.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,27.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,490.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,491.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,110.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,2880.0,28.0,527.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,2880.0,2880.0,29.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,466.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,106.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,40.0,527.0
Maligne nieuwvorming vulva (ov),TC103,M11,SC13,DTC795016,75.0,827,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,0.0,1.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,492.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,43200.0,111.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,15840.0,46.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,1440.0,141120.0,493.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,1440.0,43200.0,112.0,527.0
maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,1440.0,15840.0,47.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-21 23:00:00,1380.0,9.0,3.0,23.0,0.0,141120.0,486.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-22 23:00:00,1380.0,9.0,4.0,23.0,0.0,142560.0,494.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-22 23:00:00,1380.0,9.0,4.0,23.0,0.0,142560.0,495.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-22 23:00:00,1380.0,9.0,4.0,23.0,1440.0,142560.0,496.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-23 23:00:00,1380.0,9.0,5.0,23.0,0.0,144000.0,497.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-23 23:00:00,1380.0,9.0,5.0,23.0,0.0,144000.0,498.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-23 23:00:00,1380.0,9.0,5.0,23.0,1440.0,144000.0,499.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,504.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,10.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,7.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,506.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,13.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,10.0,526.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,60480.0,3.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,511.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,18.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,15.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,512.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,19.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,16.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,20.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,17.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,513.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,23.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,20.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,24.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,21.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,23.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,376487.0,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,515.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,516.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,26.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,24.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,518.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,27.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,25.0,526.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,7200.0,32.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,501.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,502.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,503.0,526.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,60480.0,2.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,6.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,7.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,8.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,3.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,4.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,5.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,9.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,6.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,11.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,8.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,505.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,12.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,9.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,507.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,14.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,11.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,508.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,15.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,12.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,509.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,16.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,13.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,510.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,17.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,14.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,21.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,18.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,22.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,19.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,514.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,25.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,22.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,517.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,28.0,526.0
maligniteit endometrium,TC23,DC106,SC61,DTC785561,70.0,823,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,10080.0,26.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,519.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,520.0,526.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,60480.0,4.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,29.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,24480.0,30.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC387070,SRA4,Section 5,SC62,Radiology,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,521.0,526.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,20160.0,6.0,526.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,15840.0,20160.0,7.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,500.0,526.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,7200.0,30.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,40320.0,49.0,526.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,17280.0,24480.0,31.0,526.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,60480.0,60480.0,5.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,7200.0,40320.0,50.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,145440.0,522.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,1440.0,145440.0,523.0,526.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,4320.0,7200.0,33.0,526.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,other,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-09-24 23:00:00,1380.0,9.0,6.0,23.0,0.0,7200.0,31.0,526.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,1.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,146880.0,524.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,48960.0,113.0,527.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,2.0,527.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,5760.0,48960.0,114.0,527.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,0.0,3.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,0.0,146880.0,525.0,527.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-25 23:00:00,1380.0,9.0,0.0,23.0,1440.0,146880.0,526.0,527.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,1.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,531.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,6.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,532.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,34.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,9.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,538.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,14.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,539.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,15.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,540.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,16.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,541.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,19.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,542.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,20.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,23.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,25.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,545.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,26.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,528.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,529.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,32.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,33.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,2.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,3.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,4.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,530.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,5.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,7.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,8.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,533.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,534.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,10.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,535.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,11.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,536.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,12.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,537.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,13.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,35.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,17.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,36.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,18.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,543.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,21.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC372441,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,22.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC376406,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,24.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,544.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,37.0,526.0
Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC583868,65.0,829,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,0.0,27.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,546.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,38.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,527.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,31.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,11520.0,39.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,0.0,148320.0,547.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,11520.0,11520.0,40.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-26 23:00:00,1380.0,9.0,1.0,23.0,1440.0,148320.0,548.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,339488A,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,43.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,44.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,117.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,118.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,7.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,123.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,12.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,124.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,13.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,125.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,14.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,127.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,15.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,128.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,372440A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,19.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,20.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,47.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,376487.0,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,22.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,130.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,45.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,550.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,115.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,116.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,46.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,2.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,3.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,4.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,5.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,6.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,551.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,119.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,8.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,120.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,9.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,552.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,121.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,10.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,553.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,122.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,11.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,126.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,129.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,17.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC372439,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,18.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,50.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,51.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC378431,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,24.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,25.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,554.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,51840.0,131.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,48.0,526.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,2880.0,51840.0,132.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,4320.0,44640.0,51.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,549.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,41.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,1.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC40016,F5NO,Section 1,SC61,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,48.0,526.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,60480.0,109440.0,69.0,526.0
maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,50400.0,50400.0,10.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,149760.0,555.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,1440.0,12960.0,49.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,1440.0,149760.0,556.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC619600,F5NO,Section 1,SC61,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,52.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,53.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,10080.0,80640.0,54.0,526.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,other,other,Section 1,SC61,Nursing ward,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,80640.0,49.0,526.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,12960.0,42.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,other,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,16.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,21.0,526.0
Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,deviant,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-27 23:00:00,1380.0,9.0,2.0,23.0,0.0,0.0,23.0,526.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,560.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,561.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,566.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,567.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,568.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,569.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,22.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,572.0,525.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,14400.0,50.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,558.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,559.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,19.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,562.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,563.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,564.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,565.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,20.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,21.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,570.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,23.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,571.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,72000.0,24.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,573.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,574.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,25920.0,72000.0,25.0,525.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,1440.0,14400.0,51.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,557.0,525.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,11520.0,131040.0,13.0,525.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,5760.0,66240.0,6.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,0.0,151200.0,575.0,525.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-09-28 23:00:00,1380.0,9.0,3.0,23.0,1440.0,151200.0,576.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,339988E,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,6.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,7.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,28.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,29.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,26.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,4.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,8.0,525.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,30240.0,151200.0,128.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,9.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC610001,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,30.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,31.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,32.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,8640.0,8640.0,10.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,33.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,4320.0,76320.0,34.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,other,other,Section 1,SC61,Nursing ward,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,76320.0,27.0,525.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,other,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-10-01 23:00:00,1380.0,10.0,6.0,23.0,0.0,8640.0,5.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,36.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,42.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,41.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370488H,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,47.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,49.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,50.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC356132,LVPT,Section 4,SC88,Pathology,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,37.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,38.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,39.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,40.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,43.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,44.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,45.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,46.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,48.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC378403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,51.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,52.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,54.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,55.0,525.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,50400.0,126720.0,155.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,56.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,35.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,57.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,1440.0,77760.0,58.0,525.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-02 23:00:00,1380.0,10.0,0.0,23.0,0.0,77760.0,53.0,525.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,5.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,79200.0,61.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,8.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,13.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,14.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,15.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,18.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,19.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,21.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,22.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,23.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,24.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,79200.0,60.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,3.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,4.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,6.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,7.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,9.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,10.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,11.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,12.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,16.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,17.0,526.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC593116,67.0,832,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,20.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,79200.0,62.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,79200.0,59.0,526.0
maligniteit cervix,TC101,M13,SC7,other,38.0,831,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,526.0
maligniteit cervix,TC101,M13,SC7,other,38.0,831,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,0.0,79200.0,63.0,526.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-10-03 23:00:00,1380.0,10.0,1.0,23.0,1440.0,79200.0,64.0,526.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,15.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,18.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,23.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,24.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,25.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,28.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,29.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,31.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,32.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,33.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,11.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,12.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,13.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,14.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,16.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,17.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,19.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,20.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,21.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,22.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,26.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,27.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,30.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,34.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,36.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,37.0,524.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,14400.0,38880.0,32.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,4320.0,12960.0,38.0,524.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,14400.0,21600.0,34.0,524.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,other,other,Section 4,SC86,Medical Microbiology,1.0,2006-10-04 23:00:00,1380.0,10.0,2.0,23.0,0.0,12960.0,35.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,5.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,8.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,13.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,14.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,15.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,18.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,19.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,21.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,22.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,1.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,2.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,3.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,4.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,6.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,7.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,9.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,10.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,11.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,12.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,16.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,17.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,20.0,524.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC612383,53.0,833,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,23.0,524.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,10080.0,141120.0,14.0,524.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,34560.0,86400.0,80.0,524.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-05 23:00:00,1380.0,10.0,3.0,23.0,15840.0,36000.0,8.0,524.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,54.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,59.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,60.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,52.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,53.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,55.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,56.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,57.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,58.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,61.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,62.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,67680.0,133.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,15840.0,67680.0,134.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,0.0,60480.0,63.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-08 23:00:00,1380.0,10.0,6.0,23.0,15840.0,60480.0,64.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,69120.0,136.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,69120.0,137.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,69120.0,135.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,61920.0,65.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,69120.0,138.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,61920.0,66.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,0.0,69120.0,139.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,1440.0,61920.0,67.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-09 23:00:00,1380.0,10.0,0.0,23.0,1440.0,69120.0,140.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,56.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,62.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,64.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,53.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,54.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,55.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,57.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,58.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,59.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,60.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,61.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,63.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,65.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,66.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,70560.0,141.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,63360.0,68.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,52.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,31680.0,67.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,0.0,70560.0,142.0,521.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,1440.0,63360.0,69.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,17280.0,31680.0,68.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-10 23:00:00,1380.0,10.0,1.0,23.0,1440.0,70560.0,143.0,521.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,68.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,70.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,83.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,84.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,85.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,80.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,81.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,82.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,75.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,76.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,77.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,79.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,80.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,97.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,38.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,42.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,103.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,104.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,105.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,82.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,106.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,107.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,108.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,84.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,379000A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,86.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC355105,LVPT,Section 4,SC88,Pathology,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,71.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,72.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,65.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,66.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,34.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,35.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,73.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,74.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,75.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,76.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,67.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,77.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,78.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,79.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,69.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,71.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,72.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,86.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,87.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,88.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,89.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,90.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,91.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,73.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,92.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,93.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,94.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,74.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,95.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,96.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,36.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,37.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,78.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,98.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,99.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,100.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,81.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,39.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,40.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,41.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,101.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,102.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,83.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,109.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,110.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,111.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,43.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,112.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC378729,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,90720.0,85.0,520.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,11520.0,90720.0,87.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,44.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,113.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,114.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,115.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,116.0,520.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,10080.0,23040.0,39.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,33.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,69.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,12960.0,139680.0,156.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,45.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,48960.0,46.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,117.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,10080.0,48960.0,47.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,118.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,1440.0,33120.0,119.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-10-11 23:00:00,1380.0,10.0,2.0,23.0,0.0,33120.0,70.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,330001B,H1NO,Section 3,SC20,Recovery room / high care,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,49.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,5.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,56.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,8.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,55.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,13.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,14.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,15.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,18.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,19.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,21.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,64.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,65.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,22.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,23.0,521.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,20160.0,86400.0,7.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC337105,OKU1,Section 3,SC7,Operating rooms,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,50.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,51.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,52.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,53.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,1.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,2.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,3.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,4.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,54.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,6.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,7.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,9.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,10.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,57.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,58.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,59.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,11.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,60.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,12.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,16.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,17.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,61.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,20.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,62.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,63.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,66.0,521.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,24.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,68.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,69.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,48.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,34560.0,120.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,70.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,1440.0,34560.0,121.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,1440.0,50400.0,71.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-12 23:00:00,1380.0,10.0,3.0,23.0,0.0,50400.0,67.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-13 23:00:00,1380.0,10.0,4.0,23.0,0.0,51840.0,72.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-13 23:00:00,1380.0,10.0,4.0,23.0,0.0,36000.0,122.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-13 23:00:00,1380.0,10.0,4.0,23.0,0.0,51840.0,73.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-13 23:00:00,1380.0,10.0,4.0,23.0,1440.0,36000.0,123.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-13 23:00:00,1380.0,10.0,4.0,23.0,1440.0,51840.0,74.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,127.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,131.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,132.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,125.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,126.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,128.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,129.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,130.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,133.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,134.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,53280.0,75.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,37440.0,124.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,0.0,53280.0,76.0,521.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,1440.0,37440.0,135.0,521.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-14 23:00:00,1380.0,10.0,5.0,23.0,1440.0,53280.0,77.0,521.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,146.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,72.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,81.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,151.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,77.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,152.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,78.0,520.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,8.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,144.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,145.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,70.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,71.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,79.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,80.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,147.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,73.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,82.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,148.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,74.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,83.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,149.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,75.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,84.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,150.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,76.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,77760.0,153.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,70560.0,79.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,85.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,78.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,38880.0,136.0,520.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,28800.0,40.0,520.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,4320.0,90720.0,9.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,7200.0,77760.0,154.0,520.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,7200.0,70560.0,80.0,520.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,5760.0,28800.0,41.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,0.0,54720.0,86.0,520.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,1440.0,38880.0,137.0,520.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-15 23:00:00,1380.0,10.0,6.0,23.0,1440.0,54720.0,87.0,520.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,156.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,157.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,158.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,159.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,160.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,161.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,162.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,163.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,155.0,519.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,72000.0,81.0,519.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,56160.0,88.0,519.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,40320.0,138.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,164.0,519.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,72000.0,82.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,165.0,519.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,1440.0,72000.0,83.0,519.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,56160.0,89.0,519.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,1440.0,40320.0,139.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,166.0,519.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,1440.0,56160.0,90.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,0.0,79200.0,167.0,519.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-16 23:00:00,1380.0,10.0,0.0,23.0,1440.0,79200.0,168.0,519.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,5.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,8.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,3.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,4.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,6.0,518.0
Adenoca: corpus uteri st IIIb,TC703,M14,SC7,other,71.0,836,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,7.0,518.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,518.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,80640.0,169.0,518.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,73440.0,84.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,57600.0,91.0,518.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,41760.0,140.0,518.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,3.0,518.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,4.0,518.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,80640.0,170.0,518.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,1440.0,73440.0,85.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,57600.0,92.0,518.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,1440.0,41760.0,141.0,518.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,80640.0,171.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,1440.0,57600.0,93.0,518.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,1440.0,80640.0,172.0,518.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835,regular,other,LVPT,Section 4,SC88,Pathology,1.0,2006-10-17 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,518.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,28800.0,180000.0,577.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,0.0,59040.0,94.0,518.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,0.0,43200.0,142.0,518.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,10080.0,100800.0,88.0,518.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,18720.0,54720.0,9.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,0.0,59040.0,95.0,518.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,1440.0,43200.0,143.0,518.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-18 23:00:00,1380.0,10.0,2.0,23.0,1440.0,59040.0,96.0,518.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,44640.0,145.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,44640.0,146.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,44640.0,147.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,44640.0,148.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,60480.0,97.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,44640.0,144.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,60480.0,98.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,1440.0,44640.0,149.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,0.0,60480.0,99.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-10-19 23:00:00,1380.0,10.0,3.0,23.0,1440.0,60480.0,100.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-20 23:00:00,1380.0,10.0,4.0,23.0,0.0,61920.0,101.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-20 23:00:00,1380.0,10.0,4.0,23.0,0.0,46080.0,150.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-20 23:00:00,1380.0,10.0,4.0,23.0,0.0,61920.0,102.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-20 23:00:00,1380.0,10.0,4.0,23.0,1440.0,46080.0,151.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-20 23:00:00,1380.0,10.0,4.0,23.0,1440.0,61920.0,103.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-21 23:00:00,1380.0,10.0,5.0,23.0,0.0,63360.0,104.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-21 23:00:00,1380.0,10.0,5.0,23.0,0.0,47520.0,152.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-21 23:00:00,1380.0,10.0,5.0,23.0,0.0,63360.0,105.0,517.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-21 23:00:00,1380.0,10.0,5.0,23.0,1440.0,47520.0,153.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-21 23:00:00,1380.0,10.0,5.0,23.0,1440.0,63360.0,106.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,36.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,37.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,38.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,6.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,175.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,88.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,9.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,14.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,15.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,16.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,180.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,93.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,19.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,181.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,94.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,20.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,22.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,23.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,24.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,25.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,1.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,173.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,174.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,86.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,87.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,39.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,2.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,3.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,4.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,5.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,7.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,8.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,176.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,89.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,10.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,11.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,177.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,90.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,12.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,178.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,91.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,13.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,40.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,17.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,41.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,18.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,179.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,92.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,21.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,42.0,517.0
maligniteit ovarium | tuba,TC803,M16,SC7,DTC587659,65.0,837,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,26.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,87840.0,182.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,80640.0,95.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,43.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,64800.0,107.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,35.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,7200.0,87840.0,183.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,7200.0,80640.0,96.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,44.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,64800.0,108.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,0.0,47520.0,45.0,517.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,1440.0,64800.0,109.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-22 23:00:00,1380.0,10.0,6.0,23.0,25920.0,47520.0,46.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,17.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC337440,OKU1,Section 3,SC7,Operating rooms,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,48960.0,48.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,48960.0,49.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,48960.0,50.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,15.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,16.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,98.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,18.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,99.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,19.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,100.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,101.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,102.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,167040.0,20.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,103.0,517.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,25920.0,167040.0,21.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,104.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,89280.0,184.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,97.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,48960.0,47.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,89280.0,185.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,105.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,89280.0,186.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,106.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,48960.0,51.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,1440.0,89280.0,187.0,517.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,1440.0,48960.0,52.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,107.0,517.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-23 23:00:00,1380.0,10.0,0.0,23.0,1440.0,82080.0,108.0,517.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,0.0,90720.0,188.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,0.0,83520.0,109.0,516.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,0.0,50400.0,53.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,0.0,90720.0,189.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,1440.0,83520.0,110.0,516.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,0.0,50400.0,54.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,1440.0,90720.0,190.0,516.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-24 23:00:00,1380.0,10.0,1.0,23.0,1440.0,50400.0,55.0,516.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,1.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,7.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,10.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,15.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,16.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,17.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,20.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,21.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,23.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,376425A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,24.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,25.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,26.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,27.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,2.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,3.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,4.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,5.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,6.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,8.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,9.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,11.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,12.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,13.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,14.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,18.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,19.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,22.0,514.0
maligne melanoom van de vulva,TC803,M11,SC7,DTC590152,72.0,838,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,28.0,514.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,14400.0,43200.0,42.0,514.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,51840.0,56.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,5760.0,53280.0,154.0,514.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,34560.0,185760.0,129.0,514.0
maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,80.0,839,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,1.0,514.0
maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,80.0,839,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,0.0,2.0,514.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,0.0,51840.0,57.0,514.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-25 23:00:00,1380.0,10.0,2.0,23.0,1440.0,51840.0,58.0,514.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,53280.0,59.0,515.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,1.0,515.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,191520.0,578.0,515.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,191520.0,579.0,515.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,11520.0,191520.0,580.0,515.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,0.0,2.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,0.0,53280.0,60.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-26 23:00:00,1380.0,10.0,3.0,23.0,1440.0,53280.0,61.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-27 23:00:00,1380.0,10.0,4.0,23.0,0.0,54720.0,62.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-27 23:00:00,1380.0,10.0,4.0,23.0,0.0,54720.0,63.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-27 23:00:00,1380.0,10.0,4.0,23.0,1440.0,54720.0,64.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-28 23:00:00,1380.0,10.0,5.0,23.0,0.0,56160.0,65.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-28 23:00:00,1380.0,10.0,5.0,23.0,0.0,56160.0,66.0,515.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-28 23:00:00,1380.0,10.0,5.0,23.0,1440.0,56160.0,67.0,515.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,8.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,193.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,113.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,11.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,16.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,17.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,18.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,198.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,118.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,21.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,199.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,119.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,22.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,24.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,25.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,26.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,1.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,2.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,3.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,191.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,192.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,111.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,112.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,4.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,5.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,6.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,7.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,9.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,10.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,194.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,114.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,12.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,13.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,195.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,115.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,14.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,196.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,116.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,15.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,19.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,20.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,197.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,117.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,23.0,516.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,0.0,27.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,97920.0,200.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,0.0,90720.0,120.0,516.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,7200.0,97920.0,201.0,516.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,7200.0,90720.0,121.0,516.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC415100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-29 23:00:00,1380.0,10.0,6.0,23.0,5760.0,48960.0,43.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,159.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,160.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,156.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,157.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,158.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,161.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,162.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,163.0,514.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,99360.0,202.0,514.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,92160.0,122.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,155.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,164.0,514.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,102240.0,139680.0,101.0,514.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,82080.0,20.0,514.0
"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,60480.0,82080.0,21.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,60480.0,165.0,514.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,99360.0,203.0,514.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,92160.0,123.0,514.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,0.0,99360.0,204.0,514.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,1440.0,92160.0,124.0,514.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,1440.0,99360.0,205.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-30 23:00:00,1380.0,10.0,0.0,23.0,7200.0,60480.0,166.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,5.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,5.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,8.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,8.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,13.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,13.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,14.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,14.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,15.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,15.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,18.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,19.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,19.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,20.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,22.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,21.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,22.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,23.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,23.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,24.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,3.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,1.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,2.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,3.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,4.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,4.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,6.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,6.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,7.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,7.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,9.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,9.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,10.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,10.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,11.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,11.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,12.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,12.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,16.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,16.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,17.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,17.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,18.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,20.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,21.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,24.0,512.0
Sereus adenoca: ovarium st IIIc,TC3101,DC823,SC13,DTC616033,43.0,843,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,25.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,25.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,26.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,100800.0,206.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,93600.0,125.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,27.0,512.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,0.0,28.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,0.0,100800.0,207.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,1440.0,93600.0,126.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-10-31 23:00:00,1380.0,10.0,1.0,23.0,1440.0,100800.0,208.0,512.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,11.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,12.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,13.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,14.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,15.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,16.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,17.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,18.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,19.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,10.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,20.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,2880.0,63360.0,167.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,21.0,508.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-01 23:00:00,1380.0,11.0,2.0,23.0,24480.0,115200.0,22.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,339486E,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,1.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,7.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,8.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,13.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,14.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,16.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,17.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,19.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,20.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,2.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,3.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,4.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,5.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,6.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,9.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,10.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,11.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,12.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,15.0,508.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC595572,63.0,844,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,0.0,18.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC380000,SRA6,Section 5,SC62,Radiology,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,0.0,2880.0,29.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-11-02 23:00:00,1380.0,11.0,3.0,23.0,2880.0,2880.0,30.0,508.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,339486E,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,211.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,129.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,216.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,134.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,25.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,217.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,135.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,26.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,25.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,28.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,29.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,30.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,27.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,25.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,31.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,29.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,209.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,210.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,127.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,128.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,212.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,130.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,213.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,131.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,214.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,132.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,215.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,133.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,27.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,26.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,28.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC378546,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,32.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,26.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,33.0,511.0
Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,30.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,31.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,108000.0,218.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,100800.0,136.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,27.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,28.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,32.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,33.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,29.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,59040.0,44.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,10080.0,59040.0,45.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,30.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,7200.0,108000.0,219.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,7200.0,100800.0,137.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,31.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,35.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,36.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,37.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,other,DRAD,Section 5,SC62,Radiology,1.0,2006-11-05 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,34.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,339486E,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,39.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,46.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,48.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,56.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,57.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,58.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,61.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,62.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,63.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,65.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,66.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,68.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,40.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,41.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,42.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,43.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,44.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,45.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,47.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,49.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,50.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,51.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,52.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,53.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,54.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,55.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,59.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,60.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,64.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,67.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,109440.0,220.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,102240.0,138.0,511.0
Mucineus adenoca. ovarium st IIIc,TC3101,DC821,SC13,DTC612366,62.0,848,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,1440.0,38.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,109440.0,221.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,102240.0,139.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,0.0,109440.0,222.0,511.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,1440.0,102240.0,140.0,511.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-06 23:00:00,1380.0,11.0,0.0,23.0,1440.0,109440.0,223.0,511.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,110880.0,224.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,103680.0,141.0,512.0
Gynaecologische tumoren,TC61,DC106,SC7,other,76.0,849,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,512.0
Gynaecologische tumoren,TC61,DC106,SC7,other,76.0,849,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,0.0,110880.0,225.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,1440.0,103680.0,142.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-07 23:00:00,1380.0,11.0,1.0,23.0,1440.0,110880.0,226.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,174.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,178.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,179.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,182.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,183.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,4320.0,4320.0,32.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,169.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,170.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,171.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,172.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,173.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,175.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,176.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,177.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,180.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,181.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,184.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,185.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,186.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,187.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,105120.0,143.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,63360.0,46.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,168.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC610001,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,1440.0,105120.0,144.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,63360.0,47.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,0.0,63360.0,48.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,4320.0,63360.0,49.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-08 23:00:00,1380.0,11.0,2.0,23.0,10080.0,73440.0,188.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,330001B,CHFO,Section 1,SC20,Cardiovascular clinics,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,190.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,106560.0,146.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,196.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,200.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,201.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,209.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,210.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488H,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,211.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,212.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,215.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,216.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,218.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,219.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,222.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC339956,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,191.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,192.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,193.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,194.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,195.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,197.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,198.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,199.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,202.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,203.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,204.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,205.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,206.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,207.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,208.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,213.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,214.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,217.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,220.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,221.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,223.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,225.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC387001,SRA1,Section 5,SC62,Radiology,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,226.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,106560.0,147.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,106560.0,145.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,189.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,64800.0,50.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,1440.0,74880.0,227.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,1440.0,106560.0,148.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,64800.0,51.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,1440.0,64800.0,52.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-09 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,224.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,235.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,238.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,244.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,245.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488H,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,246.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,247.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,249.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,250.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,254.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,229.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,230.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,231.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,232.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,233.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,234.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,236.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,237.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,239.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,240.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,241.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,242.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,243.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,248.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,251.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,252.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,253.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,256.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,257.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,108000.0,149.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,228.0,512.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,1440.0,108000.0,150.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,1440.0,76320.0,258.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-10 23:00:00,1380.0,11.0,4.0,23.0,0.0,76320.0,255.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,263.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,266.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,272.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,273.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,275.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,276.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,279.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,387042A,DRAD,Section 5,SC62,Radiology,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,282.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,260.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,261.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,262.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,264.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,265.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,267.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,268.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,269.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,270.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,271.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,274.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,277.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,278.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,280.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC387001,SRA1,Section 5,SC62,Radiology,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,281.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC387070,DRAD,Section 5,SC62,Radiology,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,283.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,0.0,77760.0,259.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-11 23:00:00,1380.0,11.0,5.0,23.0,1440.0,77760.0,284.0,512.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,134.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,232.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,153.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,55.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,287.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,288.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,289.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,138.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,237.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,158.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,60.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,139.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,238.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,159.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,61.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,290.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,25.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,131.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,132.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,229.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,230.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,151.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,152.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,286.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,53.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,54.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,231.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,133.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,135.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,233.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,154.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,56.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,136.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,234.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,155.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,57.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,137.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,235.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,156.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,58.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,236.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,157.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,59.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,140.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,26.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,141.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,239.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,110880.0,160.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,291.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,69120.0,62.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,27.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,28.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,130.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,227.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,228.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,285.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,10080.0,33.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,29.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,240.0,513.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,2880.0,110880.0,161.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,4320.0,69120.0,63.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,10080.0,34.0,513.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,5760.0,10080.0,35.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,30.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,211680.0,142.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,241.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,25920.0,211680.0,143.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,0.0,118080.0,242.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,1440.0,79200.0,292.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-12 23:00:00,1380.0,11.0,6.0,23.0,7200.0,118080.0,243.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,119520.0,245.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,297.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,300.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,306.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,307.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,308.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,310.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,311.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,313.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,315.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,23.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,294.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,295.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,296.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,298.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,299.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,301.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,302.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,303.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,304.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,305.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,24.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,25.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,309.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,312.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,314.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,26.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,316.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,27.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,317.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,119520.0,246.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,213120.0,144.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,22.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,119520.0,244.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,80640.0,293.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,197280.0,28.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,1440.0,213120.0,145.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,30240.0,197280.0,29.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,0.0,119520.0,247.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,1440.0,80640.0,318.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-13 23:00:00,1380.0,11.0,0.0,23.0,1440.0,119520.0,248.0,513.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,153.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,341.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,342.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,343.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,344.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,345.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,346.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,336.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,337.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,338.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,339.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,340.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370465Q,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,159.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,371.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,160.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,372.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,377.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,378.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,379.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,380.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,381.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,382.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,383.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,384.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,385.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,386.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,25.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC20189,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,319.0,515.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,198720.0,32.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,321.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,147.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,148.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,149.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,150.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,322.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,323.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,324.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,325.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,326.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,327.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,328.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,329.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,151.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,330.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,331.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,332.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,333.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,334.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,152.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,335.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,154.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,347.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,348.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,349.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,350.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,351.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370437,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,352.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,353.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,354.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,355.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,356.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,155.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,357.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,358.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,359.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,360.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,361.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,362.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,156.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,363.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,364.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,365.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,366.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,367.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,368.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,157.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,369.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,158.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,370.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,373.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,374.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,375.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,376.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,161.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,162.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,163.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,164.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,165.0,515.0
Sarcoom corpus uteri,TC803,M15,SC13,DTC787881,71.0,855,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,166.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,387.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,388.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,389.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,390.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,391.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,392.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,167.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,393.0,515.0
Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,25.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,394.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,168.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,169.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,170.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,395.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,396.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,397.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,398.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,399.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,400.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,25.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,26.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,146.0,515.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,198720.0,30.0,515.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,120960.0,249.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,82080.0,320.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,27.0,515.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,28.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,214560.0,171.0,515.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,1440.0,198720.0,33.0,515.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,120960.0,250.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,1440.0,82080.0,401.0,515.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,1440.0,120960.0,251.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,1440.0,214560.0,172.0,515.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-11-14 23:00:00,1380.0,11.0,1.0,23.0,0.0,198720.0,31.0,515.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,178.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,414.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,415.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,416.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,412.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,413.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,182.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,183.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,184.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,185.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,186.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,187.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,188.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,432.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,433.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,189.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,434.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,435.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,436.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,190.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,191.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,192.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,439.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,440.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,441.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,442.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,443.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,444.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,447.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,448.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,174.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,175.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,176.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,403.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,404.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,405.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,406.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,407.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,408.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,409.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,410.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,177.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,411.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,179.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,417.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,418.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,419.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,420.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,421.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,422.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,423.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,424.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,180.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,425.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,426.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,427.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,181.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,428.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,429.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,430.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,431.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,437.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,438.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,445.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,446.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,449.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,450.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,451.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,193.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,194.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,452.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,453.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,454.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,173.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,200160.0,34.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,402.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,64.0,513.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,40320.0,141120.0,89.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,20160.0,135360.0,23.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,65.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,216000.0,195.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,1440.0,200160.0,35.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,1440.0,83520.0,455.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,0.0,73440.0,66.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,4320.0,73440.0,67.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 23:00:00,1380.0,11.0,2.0,23.0,1440.0,216000.0,196.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,459.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,463.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,2880.0,29.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,2880.0,2880.0,30.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,198.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,457.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,458.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,460.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,461.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,462.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,199.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,200.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,201.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,202.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,464.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,203.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,204.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,465.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,197.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,201600.0,36.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,456.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,68.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,217440.0,205.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,1440.0,201600.0,37.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,1440.0,84960.0,466.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,0.0,74880.0,69.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,1440.0,74880.0,70.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-16 23:00:00,1380.0,11.0,3.0,23.0,1440.0,217440.0,206.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,470.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,474.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,468.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,469.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,471.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,472.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,473.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,475.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,476.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,218880.0,207.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,203040.0,38.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,0.0,86400.0,467.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,1440.0,218880.0,208.0,513.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,1440.0,203040.0,39.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-17 23:00:00,1380.0,11.0,4.0,23.0,1440.0,86400.0,477.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,481.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,485.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,479.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,480.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,482.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,483.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,484.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,486.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,487.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,220320.0,209.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,0.0,87840.0,478.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,1440.0,220320.0,210.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-18 23:00:00,1380.0,11.0,5.0,23.0,1440.0,87840.0,488.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,498.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,5.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,254.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,501.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,502.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,73.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,8.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,260.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,513.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,13.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,261.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,514.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,14.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,262.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,15.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,515.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,516.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,517.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,518.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,519.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,520.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,521.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,522.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,523.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,264.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,526.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,527.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,78.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,18.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,265.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,528.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,79.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,529.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,530.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,531.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,532.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,533.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,21.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,267.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,534.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,22.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,268.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,537.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,23.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC20113,ICU1,Section 3,SC13,ICU Adults,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,489.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,221760.0,212.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,171360.0,5.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,252.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,253.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,492.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,493.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,494.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,495.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,496.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,497.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,71.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,72.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,3.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,221760.0,213.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,4.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,6.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,499.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,500.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,7.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,503.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,255.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,504.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,505.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,74.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,9.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,506.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,256.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,507.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,257.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,508.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,10.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,258.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,509.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,510.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,75.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,11.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,259.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,511.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,512.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,76.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,12.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,524.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,16.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,525.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,17.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,263.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,77.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,266.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,20.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,221760.0,214.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,171360.0,6.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,535.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,536.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,538.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,24.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,539.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,221760.0,215.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,171360.0,7.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,128160.0,269.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,540.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,541.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,1440.0,89280.0,542.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,79200.0,80.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,25.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,26.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,221760.0,211.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,490.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,27.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,1.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,171360.0,8.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,7200.0,128160.0,270.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,4320.0,79200.0,81.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,10080.0,20160.0,36.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,151200.0,171360.0,9.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,28.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,0.0,2.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,1440.0,221760.0,216.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,ICU1,Section 3,SC89,ICU Adults,1.0,2006-11-19 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,491.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,1440.0,21600.0,37.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,1440.0,1440.0,29.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LVIR,Section 4,SC87,Medical Microbiology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,544.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LVIR,Section 4,SC87,Medical Microbiology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,545.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,549.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,223200.0,217.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,543.0,513.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,1440.0,223200.0,218.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,1440.0,90720.0,550.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,LVIR,Section 4,SC87,Medical Microbiology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,546.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,LVIR,Section 4,SC87,Medical Microbiology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,547.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,other,Section 4,SC86,Medical Microbiology,1.0,2006-11-20 23:00:00,1380.0,11.0,0.0,23.0,0.0,90720.0,548.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,555.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,561.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,562.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,563.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,564.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,565.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376425A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,566.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,567.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,2880.0,2880.0,4.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,552.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,553.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,554.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,556.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,557.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,558.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,559.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,560.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,568.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC608192,69.0,858,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,569.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,570.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC386042,SRA6,Section 5,SC62,Radiology,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,2880.0,3.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,43200.0,108000.0,110.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,0.0,92160.0,551.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-21 23:00:00,1380.0,11.0,1.0,23.0,1440.0,92160.0,571.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,577.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,579.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,585.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,586.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376467E,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,589.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC20113,H5ZU,Section 2,SC13,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,82.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,573.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,574.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,575.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,576.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,578.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,580.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,581.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,582.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,583.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,584.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372414,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,587.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,588.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,590.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378458,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,591.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,592.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,593.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,594.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,572.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,83.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,84.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,1440.0,93600.0,595.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,0.0,83520.0,85.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-22 23:00:00,1380.0,11.0,2.0,23.0,4320.0,83520.0,86.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,330001B,CHFO,Section 1,SC20,Cardiovascular clinics,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,597.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,330001B,CHFO,Section 1,SC20,Cardiovascular clinics,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,598.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,608.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,609.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,611.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,612.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,613.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,627.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,628.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,629.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,630.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,631.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,632.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,635.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,638.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,639.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,599.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,600.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,601.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,602.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,603.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,604.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,605.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,606.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,607.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,610.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,614.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,615.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,616.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,617.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,618.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,619.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,620.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,621.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,622.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,623.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,624.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,625.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,626.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,633.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,636.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,637.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,640.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,641.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,642.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,643.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,644.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,15840.0,15840.0,31.0,512.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,10080.0,12960.0,31.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,596.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,87.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,1440.0,95040.0,645.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,84960.0,88.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,1440.0,84960.0,89.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-23 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,634.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,654.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,660.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,661.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,662.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,663.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,664.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,665.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,666.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,667.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,668.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,669.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,670.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,379000A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,673.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,647.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,648.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,649.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,650.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,651.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,652.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,653.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,655.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,656.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,657.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,658.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,659.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,671.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,672.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,674.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,675.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,676.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,677.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,646.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC413489,H1NO,Section 3,SC89,Recovery room / high care,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,0.0,96480.0,678.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-24 23:00:00,1380.0,11.0,4.0,23.0,1440.0,96480.0,679.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,276.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,278.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,683.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,284.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,285.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,290.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,687.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,291.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,292.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,688.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,294.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,272.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,273.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,274.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,275.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,681.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,682.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,277.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,279.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,280.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,281.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,684.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,282.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,685.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,283.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,686.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,286.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,287.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,288.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,289.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,293.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,689.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,295.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,296.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,297.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,690.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,271.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,97920.0,680.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,298.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,0.0,136800.0,299.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,1440.0,97920.0,691.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-25 23:00:00,1380.0,11.0,5.0,23.0,8640.0,136800.0,300.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,339988E,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,35.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,696.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,698.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,92.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,703.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,97.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,704.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,98.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,705.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,100.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,706.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,101.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,708.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,710.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,103.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC339160,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,34.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,36.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,693.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,694.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,90.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,91.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,695.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,697.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,699.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,700.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,93.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,94.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,701.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,95.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,702.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,96.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,99.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,707.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,102.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,709.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,711.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,89280.0,104.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,138240.0,301.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,99360.0,692.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40016,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,32.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,37.0,512.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,17280.0,32.0,512.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,4320.0,89280.0,105.0,512.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,10080.0,181440.0,10.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,38.0,512.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,4320.0,17280.0,33.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,138240.0,302.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,1440.0,99360.0,712.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,1440.0,138240.0,303.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC619600,D0DC,Section 3,SC7,Day Centre - ward,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,4320.0,20160.0,39.0,512.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,other,DAGC,Section 3,SC7,Day Centre - treatment,1.0,2006-11-26 23:00:00,1380.0,11.0,6.0,23.0,0.0,20160.0,33.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,307.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,717.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,722.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,723.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,311.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,727.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,312.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,728.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,735.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,737.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,305.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,306.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,714.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,715.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,716.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,718.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,308.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,719.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,309.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,720.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,310.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,721.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,724.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,725.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,726.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,729.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,730.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,731.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,732.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,733.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,734.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,736.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,738.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,313.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,739.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,314.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,740.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,741.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,304.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,713.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,139680.0,315.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,742.0,512.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,1440.0,139680.0,316.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,0.0,100800.0,743.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-27 23:00:00,1380.0,11.0,0.0,23.0,1440.0,100800.0,744.0,512.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,6.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,749.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,9.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,754.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,15.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,755.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,16.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,17.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,756.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,20.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,757.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,21.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,22.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,24.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,759.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,25.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,26.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,746.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,747.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,3.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,4.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,5.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,7.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,748.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,8.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,750.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,751.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,10.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,11.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,12.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,752.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,13.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,753.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,14.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,18.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,19.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,758.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,23.0,511.0
Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,27.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,760.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,745.0,511.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,2880.0,23040.0,40.0,511.0
Adenoca: corpus uteri st IIIa,TC101,M14,SC7,other,76.0,859,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,1.0,511.0
Adenoca: corpus uteri st IIIa,TC101,M14,SC7,other,76.0,859,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,0.0,2.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,761.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,762.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,0.0,102240.0,763.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-28 23:00:00,1380.0,11.0,1.0,23.0,1440.0,102240.0,764.0,511.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,5.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,769.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,37.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,37.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,8.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,774.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,13.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,775.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,14.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,15.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,776.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,18.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,777.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,19.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,43.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,21.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,44.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,22.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,779.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,23.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,781.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,24.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,766.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,767.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,32.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,33.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,34.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,35.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,36.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,35.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,36.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,1.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,2.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,3.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,4.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,6.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,768.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,7.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,770.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,771.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,38.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,9.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,10.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,772.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,39.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,11.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,773.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,40.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,12.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,41.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,38.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,16.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,42.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,39.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,17.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,778.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,20.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,780.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,45.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,40.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,25.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,782.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,41.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,103680.0,765.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,106.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC593866,49.0,842,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,41760.0,31.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,34.0,510.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,48960.0,240480.0,581.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,210240.0,157.0,510.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,90720.0,171360.0,55.0,510.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,24480.0,135360.0,162.0,510.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,60480.0,115200.0,12.0,510.0
maligniteit cervix,TC101,M13,SC7,DTC613784,59.0,861,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,1.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,70560.0,210240.0,158.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,1440.0,24480.0,41.0,510.0
maligniteit cervix,TC101,M13,SC7,DTC613784,59.0,861,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,0.0,2.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,107.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,44.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,1440.0,103680.0,783.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,93600.0,108.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,45.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,4320.0,93600.0,109.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,4320.0,21600.0,46.0,510.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,other,SRA1,Section 5,SC62,Radiology,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,10.0,510.0
maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818,regular,other,SRA1,Section 5,SC62,Radiology,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,115200.0,11.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA4,Section 5,SC62,Radiology,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,42.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA4,Section 5,SC62,Radiology,1.0,2006-11-29 23:00:00,1380.0,11.0,2.0,23.0,0.0,21600.0,43.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,339988E,OKU1,Section 3,SC7,Operating rooms,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,48.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,787.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,52.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,53.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,54.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,55.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,792.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,793.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,795.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,796.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,49.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,50.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,785.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,786.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,51.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,788.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,789.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,790.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,791.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,794.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,797.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,56.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,784.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,110.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,47.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,105120.0,798.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,95040.0,111.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,0.0,23040.0,57.0,510.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,1440.0,95040.0,112.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,1440.0,23040.0,58.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-11-30 23:00:00,1380.0,11.0,3.0,23.0,1440.0,105120.0,799.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-01 23:00:00,1380.0,12.0,4.0,23.0,0.0,106560.0,800.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-01 23:00:00,1380.0,12.0,4.0,23.0,1440.0,106560.0,801.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-02 23:00:00,1380.0,12.0,5.0,23.0,0.0,108000.0,802.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-02 23:00:00,1380.0,12.0,5.0,23.0,1440.0,108000.0,803.0,510.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,5.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,807.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,115.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,8.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,13.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,14.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,15.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,812.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,120.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,18.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,813.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,121.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,19.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,21.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,22.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,23.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,816.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,24.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,805.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,806.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,113.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,114.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,1.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,2.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,3.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,4.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,6.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,7.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,808.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,809.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,116.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,9.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,10.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,810.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,117.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,11.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,811.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,118.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,12.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,16.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,17.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,99360.0,119.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,814.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,20.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,815.0,511.0
Sarcoom cervix (nno),TC503,M13,SC7,DTC616023,33.0,863,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,25.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,817.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,4320.0,99360.0,122.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,804.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,0.0,109440.0,818.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-12-03 23:00:00,1380.0,12.0,6.0,23.0,1440.0,109440.0,819.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,825.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,6.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,826.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,827.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,9.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,833.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,14.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,834.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,15.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,16.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,835.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,17.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,836.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,18.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,837.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,838.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,20.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,840.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,21.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,821.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,822.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,823.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,3.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,4.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,824.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,5.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,7.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,8.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,828.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,829.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,10.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,830.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,11.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,831.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,12.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,832.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,13.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,839.0,511.0
Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,56160.0,19.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,841.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,842.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,820.0,511.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,42.0,511.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,7200.0,31680.0,43.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,0.0,110880.0,843.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-12-04 23:00:00,1380.0,12.0,0.0,23.0,1440.0,110880.0,844.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,511.0
"Plaveiselcelca, cervix st IIa",TC813,M13,SC7,DTC617938,41.0,864,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,511.0
Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,112320.0,845.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,102240.0,123.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,102240.0,124.0,511.0
Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,21600.0,244800.0,219.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,21600.0,23040.0,30.0,511.0
maligniteit cervix,TC101,M13,SC7,other,53.0,865,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,511.0
maligniteit cervix,TC101,M13,SC7,other,53.0,865,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,102240.0,125.0,511.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,1440.0,112320.0,846.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,0.0,102240.0,126.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-05 23:00:00,1380.0,12.0,1.0,23.0,2880.0,102240.0,127.0,511.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,129.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,5.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,850.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,43.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,8.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,855.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,13.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,856.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,14.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,15.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,857.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,18.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,858.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,49.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,20.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,22.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,860.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,23.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,24.0,513.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867,regular,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,848.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,849.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,39.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,40.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,41.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,3.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,4.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,42.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,6.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,7.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,851.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,852.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,44.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,9.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,10.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,853.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,45.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,11.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,854.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,46.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,12.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,47.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,16.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,48.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,17.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,859.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,21.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,50.0,513.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,25.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,861.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,51.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,130.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,1440.0,24480.0,31.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,131.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,132.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,133.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,113760.0,847.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,128.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,38.0,513.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,12960.0,152640.0,317.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,21600.0,129600.0,111.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,8640.0,31680.0,59.0,513.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,513.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,3.0,513.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,52.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,1440.0,113760.0,862.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,103680.0,134.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,53.0,513.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,1440.0,103680.0,135.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-06 23:00:00,1380.0,12.0,2.0,23.0,23040.0,44640.0,54.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,6.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,66.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,9.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,65.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,869.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,14.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,870.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,15.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,16.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,19.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,20.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,22.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,72.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,872.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,73.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,23.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,874.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,24.0,512.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,regular,387042A,SRAE,Section 5,SC62,Radiology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,1440.0,3.0,512.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,regular,387042A,SRAE,Section 5,SC62,Radiology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,1440.0,4.0,512.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869,regular,387042A,SRAE,Section 5,SC62,Radiology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,1440.0,1440.0,5.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC337451,OKU1,Section 3,SC7,Operating rooms,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,56.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC355105,LVPT,Section 4,SC88,Pathology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,57.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,1.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,58.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,864.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,59.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,60.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,61.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,2.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,3.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,4.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,5.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,62.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,63.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,64.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,7.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,8.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,865.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,10.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,866.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,11.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,67.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,68.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,867.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,69.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,12.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,868.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,70.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,13.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,17.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,18.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,71.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,871.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,21.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,873.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,74.0,512.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,25.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,875.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,75.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,76.0,512.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC386902,SRA4,Section 5,SC62,Radiology,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,15840.0,197280.0,11.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,115200.0,863.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,55.0,512.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,54720.0,194400.0,102.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,1440.0,115200.0,876.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,77.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-07 23:00:00,1380.0,12.0,3.0,23.0,1440.0,46080.0,78.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,882.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,887.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,888.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,889.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,890.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,891.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,892.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,83.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,893.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,895.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,84.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,896.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,878.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,879.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,880.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,881.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,80.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,81.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,82.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,883.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,884.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,885.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,886.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,894.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,897.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,85.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,898.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,86.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,116640.0,877.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,79.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,1440.0,116640.0,899.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,87.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-08 23:00:00,1380.0,12.0,4.0,23.0,1440.0,47520.0,88.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-09 23:00:00,1380.0,12.0,5.0,23.0,0.0,118080.0,900.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-09 23:00:00,1380.0,12.0,5.0,23.0,0.0,48960.0,89.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-09 23:00:00,1380.0,12.0,5.0,23.0,1440.0,118080.0,901.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-09 23:00:00,1380.0,12.0,5.0,23.0,0.0,48960.0,90.0,512.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-09 23:00:00,1380.0,12.0,5.0,23.0,1440.0,48960.0,91.0,512.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,5.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,906.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,95.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,8.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,913.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,13.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,914.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,14.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,15.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,917.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,99.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,918.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,20.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,919.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,920.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,36.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,22.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,25.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,921.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,26.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,27.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,29.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,378609S,BLOB,Section 4,SC86,General Lab Clinical Chemistry,10.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,30.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,36000.0,171360.0,24.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,903.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,904.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,905.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,93.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,94.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,33.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,1.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,2.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,3.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,4.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,6.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,7.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,907.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,908.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,96.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,9.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,909.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,10.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,910.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,97.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,11.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,911.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,98.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,12.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,915.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,34.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,16.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,916.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,35.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,17.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,18.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,21.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,37.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,23.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC375005,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,24.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,922.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,100.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,923.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,38.0,513.0
Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,0.0,28.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,924.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,925.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,926.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,101.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,39.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,902.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,92.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,32.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC410500,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,40.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,30240.0,41.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,927.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,50400.0,102.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,5760.0,30240.0,42.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,1440.0,50400.0,103.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,1440.0,119520.0,928.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-10 23:00:00,1380.0,12.0,6.0,23.0,0.0,119520.0,912.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,58.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,59.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,60.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,61.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,54.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,55.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,56.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,57.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,84.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,85.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,86.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,87.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,88.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,89.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,90.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,91.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,38880.0,61.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC337105,OKU1,Section 3,SC7,Operating rooms,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,44.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,45.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,46.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,47.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,48.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,49.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,50.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,51.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,52.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,53.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,62.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,63.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,64.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,65.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,66.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,67.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,68.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,69.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,70.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,71.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,72.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,73.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,74.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,75.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,76.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,77.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,78.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,79.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,80.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,81.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,82.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,83.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,92.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,93.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,94.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,95.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,96.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,97.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,98.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC386042,SRA6,Section 5,SC62,Radiology,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,38880.0,60.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,120960.0,929.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,51840.0,104.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,31680.0,43.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,38880.0,62.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,7200.0,38880.0,63.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,1440.0,120960.0,930.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,0.0,51840.0,105.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,1440.0,31680.0,99.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-11 23:00:00,1380.0,12.0,0.0,23.0,1440.0,51840.0,106.0,513.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,33120.0,102.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,936.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,937.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,938.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,25.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,26.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,378609K,BLOB,Section 4,SC86,General Lab Clinical Chemistry,4.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,28.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,378609S,BLOB,Section 4,SC86,General Lab Clinical Chemistry,10.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,29.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,932.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,933.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,33120.0,101.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,934.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,935.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,939.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC375005,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,940.0,514.0
Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,27.0,514.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,514.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC623035,53.0,874,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,941.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,33120.0,103.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,122400.0,931.0,514.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,53280.0,107.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,33120.0,100.0,514.0
maligniteit cervix,TC101,M13,SC7,other,47.0,732,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,141120.0,270720.0,4.0,514.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,97920.0,184320.0,81.0,514.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,1440.0,122400.0,942.0,514.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,0.0,53280.0,108.0,514.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H1NO,Section 3,SC7,Recovery room / high care,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,1440.0,33120.0,104.0,514.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-12 23:00:00,1380.0,12.0,1.0,23.0,1440.0,53280.0,109.0,514.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,7.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,10.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,15.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,16.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,17.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,20.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,21.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,372440A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,24.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,48.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,25.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,26.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,28.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,45.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,3.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,4.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,5.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,6.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,8.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,9.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,11.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,12.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,13.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,14.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,46.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,18.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,47.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,19.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,22.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC372439,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,23.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,49.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC378431,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,27.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,50.0,515.0
Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,29.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,51.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,123840.0,943.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,54720.0,110.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,44.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,34560.0,105.0,515.0
maligniteit endometrium,TC61,DC106,SC61,other,49.0,762,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,233280.0,233280.0,3.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,52.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,1440.0,123840.0,944.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,0.0,54720.0,111.0,515.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,12960.0,44640.0,53.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,1440.0,34560.0,106.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-13 23:00:00,1380.0,12.0,2.0,23.0,1440.0,54720.0,112.0,515.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,948.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,949.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,111.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,954.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,955.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,117.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,118.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,119.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,120.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,956.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,115.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,116.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,121.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,946.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,947.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,114.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,115.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,108.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,109.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,116.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,110.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,950.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,112.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,951.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,952.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,113.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,953.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,114.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,957.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,56.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,57.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,122.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,958.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,959.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,123.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,124.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,117.0,516.0
Maligne nieuwvorming vulva (ov),TC103,M11,SC13,DTC795016,75.0,827,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,120960.0,2.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,125280.0,945.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,113.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,54.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,36000.0,107.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,1.0,516.0
Maligne nieuwvorming vulva (ov),TC103,M11,SC13,DTC795016,75.0,827,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,120960.0,120960.0,3.0,516.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,10080.0,207360.0,12.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,0.0,2.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,1440.0,125280.0,960.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,56160.0,125.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,1440.0,46080.0,58.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,1440.0,36000.0,118.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,1440.0,56160.0,126.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-12-14 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,55.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,0.0,126720.0,961.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,0.0,57600.0,127.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,59.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,0.0,37440.0,119.0,516.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,1440.0,126720.0,962.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,0.0,57600.0,128.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,1440.0,47520.0,60.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,1440.0,37440.0,120.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-15 23:00:00,1380.0,12.0,4.0,23.0,1440.0,57600.0,129.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,0.0,59040.0,130.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,0.0,48960.0,61.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,0.0,38880.0,121.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,0.0,59040.0,131.0,516.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,1440.0,48960.0,62.0,516.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,1440.0,38880.0,122.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-16 23:00:00,1380.0,12.0,5.0,23.0,1440.0,59040.0,132.0,516.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-17 23:00:00,1380.0,12.0,6.0,23.0,0.0,60480.0,133.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-17 23:00:00,1380.0,12.0,6.0,23.0,0.0,40320.0,123.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-17 23:00:00,1380.0,12.0,6.0,23.0,0.0,60480.0,134.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-17 23:00:00,1380.0,12.0,6.0,23.0,1440.0,40320.0,124.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-17 23:00:00,1380.0,12.0,6.0,23.0,1440.0,60480.0,135.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,9.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,12.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,17.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,18.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,19.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,22.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,23.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,25.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,26.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,5.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,6.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,7.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,8.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,10.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,11.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,13.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,14.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,15.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,16.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,20.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,21.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,24.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,27.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,28.0,515.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,38880.0,41760.0,29.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,61920.0,136.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,125.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,61920.0,137.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,0.0,41760.0,126.0,515.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,1440.0,61920.0,138.0,515.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2006-12-18 23:00:00,1380.0,12.0,0.0,23.0,1440.0,41760.0,127.0,515.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,31.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,32.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,33.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,34.0,513.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,35.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,63360.0,139.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,128.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,30.0,513.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,82.0,878,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,513.0
maligniteit ovarium | tuba,TC101,M16,SC7,other,82.0,878,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,36.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,63360.0,140.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,1440.0,43200.0,129.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,0.0,43200.0,37.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,1440.0,63360.0,141.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-19 23:00:00,1380.0,12.0,1.0,23.0,1440.0,43200.0,38.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,6.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,972.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,9.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,980.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,14.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,15.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,16.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,981.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,982.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,983.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,19.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,984.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,20.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,22.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,986.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,23.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,988.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,24.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,42.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC356132,LVPT,Section 4,SC88,Pathology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,43.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,964.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,965.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,966.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,967.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,968.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,3.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,4.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,969.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,5.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,970.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,7.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,971.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,8.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,973.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,10.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,974.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,975.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,11.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,976.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,977.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,12.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,978.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,979.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,13.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,17.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,18.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,985.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,21.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,987.0,513.0
Recidieven maligniteit ovarium,TC803,M16,SC7,DTC630228,58.0,880,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,25.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,989.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,990.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,991.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,992.0,513.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,5760.0,54720.0,63.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,963.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,64800.0,142.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,130.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,39.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,other,60.0,761,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,243360.0,3.0,513.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,20160.0,172800.0,318.0,513.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC563044,83.0,825,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,76320.0,132480.0,68.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,64800.0,143.0,513.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,1.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,14400.0,185760.0,25.0,513.0
Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,20160.0,20160.0,4.0,513.0
Gynaecologische tumoren,TC61,DC106,SC7,other,60.0,761,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,243360.0,243360.0,4.0,513.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,0.0,2.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,133920.0,993.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,7200.0,133920.0,994.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,64800.0,144.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,1440.0,44640.0,131.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,44.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,1440.0,64800.0,145.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,1440.0,44640.0,45.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,40.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2006-12-20 23:00:00,1380.0,12.0,2.0,23.0,0.0,44640.0,41.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1003.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1005.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1020.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,996.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,997.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,998.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,999.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1000.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1001.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1002.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1004.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1006.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1007.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1008.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1009.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1010.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1011.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1012.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1013.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1014.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1015.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1016.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1017.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1018.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1019.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1022.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1023.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1024.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1025.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1026.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1027.0,513.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,14400.0,53280.0,64.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,995.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,66240.0,146.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,132.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,46.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC410500,other,Section 6,other,other,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1028.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,1440.0,135360.0,1029.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,66240.0,147.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,1440.0,46080.0,133.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,46080.0,47.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,1440.0,66240.0,148.0,513.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,1440.0,46080.0,48.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-21 23:00:00,1380.0,12.0,3.0,23.0,0.0,135360.0,1021.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,140.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1033.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,142.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,147.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,148.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,150.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,151.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,152.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,153.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1031.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1032.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,135.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,136.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,137.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,138.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,139.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,141.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,143.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1034.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,144.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1035.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,145.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1036.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,146.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,149.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,154.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,155.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,156.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1037.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,157.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,158.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,136800.0,1030.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,0.0,47520.0,134.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,1440.0,136800.0,1038.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-22 23:00:00,1380.0,12.0,4.0,23.0,1440.0,47520.0,159.0,513.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1044.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1040.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1041.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1042.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1043.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1045.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1046.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1047.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1048.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1049.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1050.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,0.0,138240.0,1039.0,512.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-23 23:00:00,1380.0,12.0,5.0,23.0,1440.0,138240.0,1051.0,512.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,1.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,339486E,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,150.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,7.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,10.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,15.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,16.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,17.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,155.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,156.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,157.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,158.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,159.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,160.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,20.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,21.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,161.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,162.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,23.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,24.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,151.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,152.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,153.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,3.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,4.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,5.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,154.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,6.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,8.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,9.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,11.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,12.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,13.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,14.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,18.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,19.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,22.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,163.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,25.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,164.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,165.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,26.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,27.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,149.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,28.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC410500,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,29.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,30.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,166.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,73440.0,167.0,513.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,7200.0,73440.0,168.0,513.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,other,LVPT,Section 4,SC88,Pathology,1.0,2006-12-26 23:00:00,1380.0,12.0,1.0,23.0,0.0,0.0,2.0,513.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,7.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,10.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,15.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,16.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,17.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,20.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,21.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,23.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,24.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,25.0,511.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,1440.0,1440.0,31.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,3.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,4.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,5.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,6.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,8.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,9.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,11.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,12.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,13.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,14.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,18.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,19.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,22.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,26.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,27.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,18720.0,28.0,511.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,18720.0,18720.0,29.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,74880.0,169.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,0.0,74880.0,170.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-27 23:00:00,1380.0,12.0,2.0,23.0,1440.0,74880.0,171.0,511.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-28 23:00:00,1380.0,12.0,3.0,23.0,0.0,76320.0,172.0,510.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-28 23:00:00,1380.0,12.0,3.0,23.0,0.0,76320.0,173.0,510.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2006-12-28 23:00:00,1380.0,12.0,3.0,23.0,1440.0,76320.0,174.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC411100,SGEH,Section 2,SC7,Nursing ward,1.0,2006-12-31 23:00:00,1380.0,12.0,6.0,23.0,11520.0,149760.0,1052.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,66.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,71.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,72.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,64.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,65.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,67.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,68.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,69.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,70.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,72000.0,73.0,510.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,5760.0,82080.0,175.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,151200.0,1053.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,151200.0,1054.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,17280.0,72000.0,74.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,0.0,151200.0,1055.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-01 23:00:00,1380.0,1.0,0.0,23.0,1440.0,151200.0,1056.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1063.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1070.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1071.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1074.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1076.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1058.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1059.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1060.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1061.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1062.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1064.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1065.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1066.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1067.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1068.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1069.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1072.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1073.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1075.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1077.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1078.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1079.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1080.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1081.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1082.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,73440.0,75.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,73440.0,76.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1083.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,1440.0,73440.0,77.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1057.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1084.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,0.0,152640.0,1085.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-02 23:00:00,1380.0,1.0,1.0,23.0,1440.0,152640.0,1086.0,510.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,387042A,SRA6,Section 5,SC62,Radiology,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,20160.0,20160.0,4.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,79.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,80.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,81.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,82.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,83.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,84.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,154080.0,1087.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,78.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,85.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,1440.0,154080.0,1088.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,74880.0,86.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,1440.0,74880.0,87.0,510.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,other,SRA4,Section 5,SC62,Radiology,1.0,2007-01-03 23:00:00,1380.0,1.0,2.0,23.0,0.0,20160.0,3.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-04 23:00:00,1380.0,1.0,3.0,23.0,0.0,155520.0,1089.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-04 23:00:00,1380.0,1.0,3.0,23.0,0.0,76320.0,88.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-04 23:00:00,1380.0,1.0,3.0,23.0,1440.0,155520.0,1090.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-04 23:00:00,1380.0,1.0,3.0,23.0,1440.0,76320.0,89.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,68.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,165.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,71.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,75.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,76.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,77.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,170.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,79.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,171.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,80.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,82.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,83.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,163.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,164.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,65.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,66.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,67.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,69.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,70.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,166.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,72.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,167.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,73.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,168.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,74.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,169.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,78.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,81.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,191520.0,172.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,84.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,0.0,77760.0,85.0,509.0
Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC565851,61.0,807,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,56160.0,191520.0,173.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-07 23:00:00,1380.0,1.0,6.0,23.0,24480.0,77760.0,86.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1093.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,92.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1098.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,97.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1099.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,98.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1091.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1092.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,90.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,91.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1094.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,93.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1095.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,94.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1096.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,95.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1097.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,96.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,161280.0,1100.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,0.0,82080.0,99.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,1440.0,79200.0,87.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,5760.0,161280.0,1101.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-08 23:00:00,1380.0,1.0,0.0,23.0,5760.0,82080.0,100.0,509.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,7.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,33.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,10.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,15.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,16.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,17.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,20.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,21.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,36.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,23.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,24.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,25.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,26.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,89.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,31.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,32.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,3.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,4.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,5.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,6.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,8.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,9.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,11.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,12.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,13.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,14.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,90.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,34.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,18.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,91.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,35.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,19.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,22.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,37.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,92.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,93.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,38.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,39.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,94.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,40.0,510.0
Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,27.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,95.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,41.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,162720.0,1102.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,88.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,30.0,510.0
Adenoca:  cervix st Ib,TC101,M13,SC7,other,87.0,883,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,510.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,28800.0,201600.0,319.0,510.0
Adenoca:  cervix st Ib,TC101,M13,SC7,other,87.0,883,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,162720.0,1103.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,96.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,37440.0,42.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,1440.0,162720.0,1104.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,97.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,18720.0,37440.0,43.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,98.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,0.0,80640.0,99.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-09 23:00:00,1380.0,1.0,1.0,23.0,1440.0,80640.0,100.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1108.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,59.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,60.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,61.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,62.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,8.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,55.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,56.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,57.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,58.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,12.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,13.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,14.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,85.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,86.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,87.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,88.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,89.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,90.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,91.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,92.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC337105,OKU1,Section 3,SC7,Operating rooms,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,45.0,506.0
Adenoca:  cervix st Ib,TC101,M13,SC7,other,87.0,883,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,3.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,46.0,506.0
Adenoca:  cervix st Ib,TC101,M13,SC7,other,87.0,883,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,1440.0,1440.0,4.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1106.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1107.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,47.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,48.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,49.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,50.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,5.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,6.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,51.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,52.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,53.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,54.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,7.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1109.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,9.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,63.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,64.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,65.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,66.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,67.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,68.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,69.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,70.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1110.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,71.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,72.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,73.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,74.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,10.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1111.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,75.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,76.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,77.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,78.0,506.0
Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,30240.0,11.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,79.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,80.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,81.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,82.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,83.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,84.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,93.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,94.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,95.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,96.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1112.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,97.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,98.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,99.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,100.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390004,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,82080.0,102.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC393628,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,82080.0,103.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,164160.0,1105.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,84960.0,101.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,82080.0,101.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,38880.0,44.0,506.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,77760.0,280800.0,40.0,506.0
Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,151200.0,260640.0,70.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,84960.0,102.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,1440.0,164160.0,1113.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,2880.0,84960.0,103.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,0.0,82080.0,104.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,1440.0,38880.0,101.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-10 23:00:00,1380.0,1.0,2.0,23.0,1440.0,82080.0,105.0,506.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,21600.0,23040.0,32.0,505.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,0.0,86400.0,104.0,505.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,0.0,83520.0,106.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,0.0,40320.0,102.0,505.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,40320.0,247680.0,13.0,505.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,1440.0,86400.0,105.0,505.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,0.0,83520.0,107.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,0.0,40320.0,103.0,505.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,1440.0,83520.0,108.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-11 23:00:00,1380.0,1.0,3.0,23.0,1440.0,40320.0,104.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-12 23:00:00,1380.0,1.0,4.0,23.0,0.0,41760.0,105.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-12 23:00:00,1380.0,1.0,4.0,23.0,1440.0,41760.0,106.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1119.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,110.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1124.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1125.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1126.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1127.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC339956,H1NO,Section 3,SC89,Recovery room / high care,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1115.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1116.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1117.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,108.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,109.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1118.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1120.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1121.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1122.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,111.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,112.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1123.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,113.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,114.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,115.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,116.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1128.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1129.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,117.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,118.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,168480.0,1114.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,107.0,505.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,4320.0,168480.0,1130.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,0.0,43200.0,119.0,505.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-13 23:00:00,1380.0,1.0,5.0,23.0,1440.0,43200.0,120.0,505.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,5.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1135.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,138.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,111.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,8.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,13.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,14.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,15.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1142.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,143.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,116.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,18.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1143.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,144.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,117.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,19.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,21.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,145.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,22.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1146.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,23.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1147.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,24.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1132.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1133.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1134.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,136.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,137.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,109.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,110.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,3.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,4.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,6.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,7.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1136.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,139.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,112.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,9.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,10.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1137.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,140.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,113.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,11.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1138.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,141.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,114.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,12.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1139.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,16.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1140.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,17.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1141.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,142.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,115.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,20.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1144.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1145.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1148.0,506.0
Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,25.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1149.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1150.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1151.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,146.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,118.0,506.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,100800.0,176.0,506.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,18720.0,100800.0,177.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1131.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,44640.0,121.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,3.0,506.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,506.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,66240.0,237600.0,56.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,169920.0,1152.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,159840.0,147.0,506.0
"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,56160.0,159840.0,148.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,4320.0,87840.0,121.0,506.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,4.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,5.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,1440.0,169920.0,1153.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,44640.0,122.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,6.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,7.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,8.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,9.0,506.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,10.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,44640.0,123.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,1440.0,44640.0,124.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA1,Section 5,SC62,Radiology,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,119.0,506.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA1,Section 5,SC62,Radiology,1.0,2007-01-14 23:00:00,1380.0,1.0,6.0,23.0,0.0,87840.0,120.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,330001B,CHFO,Section 1,SC20,Cardiovascular clinics,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1155.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1159.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,108.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,113.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,114.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1163.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1164.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1156.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1157.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,106.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,107.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1158.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1160.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,109.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1161.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,110.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1162.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,111.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,112.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1165.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1166.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,92160.0,115.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1154.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,46080.0,125.0,506.0
Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,87840.0,228960.0,90.0,506.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,5760.0,92160.0,116.0,506.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781,regular,AC415100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,5760.0,253440.0,14.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1167.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,46080.0,126.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,1440.0,46080.0,128.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,171360.0,1168.0,506.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,1440.0,171360.0,1169.0,506.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-15 23:00:00,1380.0,1.0,0.0,23.0,0.0,46080.0,127.0,506.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,6.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1174.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,9.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,14.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,15.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,16.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1178.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,19.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1179.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,20.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,376487.0,SLVE,Section 4,SC86,Special lab radiology,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,16.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1180.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,22.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1181.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,23.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1171.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1172.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,12.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,13.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,3.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,4.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,5.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,7.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1173.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,8.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1175.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,10.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,11.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1176.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,12.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1177.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,13.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,14.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,17.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,15.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,18.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,21.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,17.0,508.0
Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,24.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1182.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1183.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,18.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,36000.0,83520.0,160.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1170.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,47520.0,129.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,11.0,508.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,3.0,508.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC410500,SAPA,Section 6,SC89,Anesthesiology clinic,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,19.0,508.0
Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,93600.0,93600.0,9.0,508.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,2880.0,2880.0,4.0,508.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,20.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,172800.0,1184.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,1440.0,47520.0,130.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,0.0,2880.0,21.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,2880.0,2880.0,22.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-16 23:00:00,1380.0,1.0,1.0,23.0,1440.0,172800.0,1185.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1195.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1196.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,6.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,6.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1198.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,35.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,36.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,9.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,8.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,14.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,15.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,16.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1202.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1203.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,17.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,15.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,18.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,16.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,20.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,18.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,41.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,42.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1206.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,43.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,44.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,21.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378216A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1207.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1208.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,22.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,19.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,25.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,26.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,27.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,28.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,2.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,29.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,30.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1187.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1188.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1189.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1190.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1191.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1192.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,123.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,31.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,32.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,3.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,4.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,3.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,4.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,5.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1193.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1194.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,5.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,33.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,34.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,7.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1197.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,8.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,7.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1199.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,10.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,9.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,11.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,10.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1200.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,37.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,38.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,12.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,11.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1201.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,39.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,40.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,13.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,12.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,124.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,13.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,125.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,14.0,509.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,1440.0,19.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,17.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,45.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,46.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,126.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,20.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1209.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1210.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1211.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1212.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,127.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,47.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,48.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1186.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,95040.0,117.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,122.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,48960.0,131.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,23.0,509.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,0.0,1.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,95040.0,118.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,128.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,1440.0,174240.0,1213.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,2880.0,95040.0,119.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,92160.0,129.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,48960.0,132.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,49.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,4320.0,92160.0,130.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,1440.0,4320.0,50.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1204.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,174240.0,1205.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,1440.0,48960.0,133.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,other,OKU1,Section 3,SC7,Operating rooms,1.0,2007-01-17 23:00:00,1380.0,1.0,2.0,23.0,0.0,4320.0,24.0,509.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,regular,339171A,other,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,0.0,1.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1222.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1223.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1225.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,54.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370465Q,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1230.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1231.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1235.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,57.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1239.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378216A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1240.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1241.0,510.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,0.0,2.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1215.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1216.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1217.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1218.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1219.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,52.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,53.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1220.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1221.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1224.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1226.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370424,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1227.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1228.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1229.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,55.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,56.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,58.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,132.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,133.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,59.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,60.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,61.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,62.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,63.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1243.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1244.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1245.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1246.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1247.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,64.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1214.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,96480.0,120.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,131.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,50400.0,134.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,51.0,510.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,0.0,3.0,510.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,0.0,4.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1248.0,510.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,1440.0,96480.0,121.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,134.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,50400.0,135.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,5760.0,65.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,135.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,1440.0,5760.0,66.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,1440.0,175680.0,1249.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,93600.0,136.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,1440.0,93600.0,137.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1232.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,other,Section 4,SC86,other,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1233.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,other,Section 4,SC86,other,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1234.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1236.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1237.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1238.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,0.0,175680.0,1242.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-18 23:00:00,1380.0,1.0,3.0,23.0,1440.0,50400.0,136.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1256.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1257.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1261.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1262.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1251.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1252.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1253.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1254.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1255.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1258.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1259.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1260.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1263.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1264.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1265.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,177120.0,1250.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,95040.0,138.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,51840.0,137.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,7200.0,67.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,1440.0,177120.0,1266.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,95040.0,140.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,1440.0,51840.0,138.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,7200.0,68.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,1440.0,95040.0,141.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,1440.0,7200.0,69.0,510.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2007-01-19 23:00:00,1380.0,1.0,4.0,23.0,0.0,95040.0,139.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,73.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1273.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1274.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1275.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1276.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1277.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,77.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1278.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1279.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1280.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,78.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1281.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,80.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1268.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1269.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,71.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,72.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1270.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,74.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1271.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,75.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1272.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,76.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,79.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1282.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,81.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1283.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1284.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,82.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,178560.0,1267.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,53280.0,139.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,70.0,510.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,1440.0,178560.0,1285.0,510.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,1440.0,53280.0,140.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,0.0,8640.0,83.0,510.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-20 23:00:00,1380.0,1.0,5.0,23.0,1440.0,8640.0,84.0,510.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,34.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,35.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,36.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,5.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1292.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,144.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,39.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,89.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,8.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,13.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,14.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,15.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,93.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,94.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,149.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,95.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,18.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,150.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,19.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,96.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,21.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,22.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1300.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,23.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1302.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,24.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1287.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1288.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1289.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1290.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,142.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,143.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,37.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,38.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,86.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,87.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,88.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,3.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1291.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,4.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,6.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,7.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1293.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,145.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,90.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,9.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,10.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1294.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,146.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,91.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,11.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1295.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,147.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,92.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,12.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1296.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,40.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,16.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1297.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,41.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,17.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,148.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,20.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1298.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1299.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1301.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,97.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1303.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,42.0,509.0
Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,25.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1304.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1305.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1306.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,97920.0,151.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,43.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,98.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,99.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1286.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,54720.0,141.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,33.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,85.0,509.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,2880.0,97920.0,152.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,44.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1307.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,54720.0,142.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,37440.0,45.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,10080.0,100.0,509.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,14400.0,37440.0,46.0,509.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,1440.0,10080.0,101.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1308.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,0.0,180000.0,1309.0,509.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,1440.0,180000.0,1310.0,509.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-21 23:00:00,1380.0,1.0,6.0,23.0,1440.0,54720.0,143.0,509.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,124.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,129.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,130.0,508.0
Adenoca:  cervix st Ib,TC101,M13,SC7,other,87.0,883,regular,387042A,SRA6,Section 5,SC62,Radiology,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,17280.0,18720.0,5.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC337440,OKU1,Section 3,SC7,Operating rooms,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,38880.0,48.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC339956,H1NO,Section 3,SC89,Recovery room / high care,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,181440.0,1312.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,38880.0,49.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,122.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,123.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,125.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,126.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,127.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,128.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,102240.0,131.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,181440.0,1311.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,38880.0,47.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,11520.0,102.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,181440.0,1313.0,508.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,5760.0,102240.0,132.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,181440.0,1314.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,38880.0,50.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,0.0,11520.0,103.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,1440.0,38880.0,51.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,1440.0,11520.0,104.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,1440.0,181440.0,1315.0,508.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-22 23:00:00,1380.0,1.0,0.0,23.0,1440.0,56160.0,144.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1319.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,108.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1324.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,112.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1325.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1326.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1327.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1317.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1318.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,106.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,107.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1320.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,109.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1321.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,110.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1322.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,111.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1323.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,113.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1328.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1329.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1330.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,114.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,182880.0,1316.0,508.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,100800.0,153.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,40320.0,52.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,105.0,508.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,20160.0,221760.0,320.0,508.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,100800.0,154.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,1440.0,182880.0,1331.0,508.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,100800.0,155.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,40320.0,53.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,0.0,12960.0,115.0,508.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,2880.0,100800.0,156.0,508.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,1440.0,40320.0,54.0,508.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-23 23:00:00,1380.0,1.0,1.0,23.0,1440.0,12960.0,116.0,508.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1336.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,41760.0,57.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,120.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1340.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1341.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1342.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1343.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1333.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1334.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,41760.0,56.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,118.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,119.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1335.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1337.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,121.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1338.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,122.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1339.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,123.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1344.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1345.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,41760.0,58.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,124.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1332.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,105120.0,133.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,102240.0,157.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,41760.0,55.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,117.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,105120.0,134.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,184320.0,1346.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,2880.0,105120.0,135.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,102240.0,158.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,41760.0,59.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,0.0,14400.0,125.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,1440.0,102240.0,159.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,1440.0,41760.0,60.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,1440.0,14400.0,126.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-24 23:00:00,1380.0,1.0,2.0,23.0,1440.0,184320.0,1347.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1353.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,163.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,131.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1358.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,135.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1359.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1360.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,136.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1361.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1350.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1351.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,161.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,162.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,128.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,129.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1352.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,130.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1354.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,164.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,132.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1355.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1356.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,165.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,133.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1357.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,166.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,134.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1362.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,167.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,137.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1363.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,168.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,138.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC386041,SRA6,Section 5,SC62,Radiology,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,170.0,503.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC386902,SRA4,Section 5,SC62,Radiology,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,12960.0,15840.0,5.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1348.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,106560.0,136.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,160.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,43200.0,61.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,127.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1364.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,1440.0,106560.0,137.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,171.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,43200.0,62.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,15840.0,139.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,1440.0,103680.0,172.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,1440.0,43200.0,63.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,1440.0,15840.0,140.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,1440.0,185760.0,1365.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,H1NO,Section 3,SC89,Recovery room / high care,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,185760.0,1349.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA6,Section 5,SC62,Radiology,1.0,2007-01-25 23:00:00,1380.0,1.0,3.0,23.0,0.0,103680.0,169.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,179.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378216A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,180.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,174.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,175.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,176.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,177.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,178.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,181.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,182.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,183.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,187200.0,1366.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,173.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,44640.0,64.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,17280.0,141.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,1440.0,187200.0,1367.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,105120.0,184.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,44640.0,65.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,0.0,17280.0,142.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,1440.0,105120.0,185.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,1440.0,44640.0,66.0,503.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-26 23:00:00,1380.0,1.0,4.0,23.0,1440.0,17280.0,143.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1375.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1380.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1381.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1382.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1383.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1384.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1385.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1386.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1387.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1388.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1389.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1391.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1369.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1370.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1371.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1372.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,187.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1373.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1374.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1376.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,188.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1377.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1378.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,189.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1379.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,190.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1390.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1392.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,191.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1393.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,192.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,188640.0,1368.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,186.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,46080.0,67.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,1440.0,188640.0,1394.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,106560.0,193.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,0.0,46080.0,68.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,1440.0,106560.0,194.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-27 23:00:00,1380.0,1.0,5.0,23.0,1440.0,46080.0,69.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,6.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,5.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,5.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1399.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,198.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,9.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,8.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,6.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,14.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,13.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,15.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,14.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,16.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,15.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1404.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,204.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,19.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,18.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1405.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,205.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,20.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,19.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,21.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1406.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,206.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,24.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,22.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1407.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,207.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,25.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,23.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,3.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,4.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1396.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1397.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,196.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,197.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,3.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,4.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,1.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,2.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,3.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,5.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,4.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,7.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,6.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1398.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,8.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,7.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1400.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,199.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,10.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,9.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,200.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,11.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,10.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1401.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,201.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,12.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,11.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1402.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,202.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,13.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,12.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,17.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,16.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,18.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,17.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1403.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,203.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,21.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,20.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC372441,SLVE,Section 4,SC86,Special lab radiology,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,22.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC376406,SLVE,Section 4,SC86,Special lab radiology,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,23.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,26.0,503.0
Adenoca: corpus uteri st Ia,TC803,M14,SC7,DTC654353,38.0,893,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,24.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1408.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,208.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,7.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1409.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,209.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,27.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,210.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,28.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1395.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,195.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,47520.0,70.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,29.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,309600.0,8.0,503.0
maligniteit vagina,TC61,DC106,SC61,DTC811126,40.0,753,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,309600.0,309600.0,9.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,0.0,30.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,190080.0,1410.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,108000.0,211.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,47520.0,71.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,1440.0,108000.0,212.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,0.0,47520.0,72.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,1440.0,190080.0,1411.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,other,other,Section 2,other,Nursing ward,1.0,2007-01-28 23:00:00,1380.0,1.0,6.0,23.0,1440.0,47520.0,73.0,503.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,9.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,140.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,48960.0,76.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,12.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,17.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,18.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,19.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,20.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,21.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,145.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,25.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,146.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,26.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,28.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,29.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,31.0,504.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,1440.0,1440.0,31.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,138.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,139.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,48960.0,75.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,2.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,3.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,4.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,5.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,6.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,7.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,8.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,10.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,11.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,141.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,13.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,14.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,142.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,15.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,143.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,16.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,22.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,23.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,144.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,24.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,27.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,30.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,32.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,112320.0,147.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,48960.0,77.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,191520.0,1412.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,109440.0,213.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,48960.0,74.0,504.0
Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,0.0,1.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,5760.0,112320.0,148.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,1440.0,191520.0,1413.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,109440.0,214.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,0.0,48960.0,78.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,1440.0,109440.0,215.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-29 23:00:00,1380.0,1.0,0.0,23.0,1440.0,48960.0,79.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,6.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,5.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,9.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,8.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,14.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,13.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,15.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,14.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,16.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,15.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,19.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,18.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,20.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,19.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,21.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,22.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,22.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,23.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,23.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,3.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,4.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,1.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,2.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,3.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,5.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,4.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,7.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,6.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,8.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,7.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,10.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,9.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,11.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,10.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,12.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,11.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,13.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,12.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,17.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,16.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,18.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,17.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,21.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,20.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,24.0,504.0
Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC656079,67.0,896,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,24.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,25.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,26.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC380077,SRA4,Section 5,SC62,Radiology,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,110880.0,218.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,27.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,192960.0,1414.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,110880.0,216.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,50400.0,80.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,23040.0,6.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,28.0,504.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,0.0,29.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC610001,F5NO,Section 1,SC61,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,7200.0,23040.0,7.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,192960.0,1415.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,110880.0,220.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,50400.0,81.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,1440.0,110880.0,221.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,1440.0,50400.0,82.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,1440.0,192960.0,1416.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,LVPT,Section 4,SC88,Pathology,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,110880.0,217.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,SRA4,Section 5,SC62,Radiology,1.0,2007-01-30 23:00:00,1380.0,1.0,1.0,23.0,0.0,110880.0,219.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,24480.0,9.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1422.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1424.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,228.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1429.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,234.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1430.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,235.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,236.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1432.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1418.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1419.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1420.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,223.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,224.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,225.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1421.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,226.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1423.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,227.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1425.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1426.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,229.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1427.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,230.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1428.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,231.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,232.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,233.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,237.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,238.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,239.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1433.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1434.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1435.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,240.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,24480.0,10.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,24480.0,11.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,24480.0,12.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1417.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,222.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,51840.0,83.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,24480.0,8.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,1440.0,194400.0,1436.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,112320.0,241.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,51840.0,84.0,504.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,1440.0,24480.0,13.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,1440.0,112320.0,242.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,1440.0,51840.0,85.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,other,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 23:00:00,1380.0,1.0,2.0,23.0,0.0,194400.0,1431.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1441.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,247.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1445.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,252.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1446.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1447.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,253.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1438.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1439.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,244.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,245.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1440.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,246.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1442.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,248.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1443.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,249.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1444.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,250.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,251.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1448.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,254.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1449.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,255.0,503.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC386002,SRAS,Section 5,SC62,Radiology,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,2880.0,30.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC387090,SRA6,Section 5,SC62,Radiology,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,4320.0,5760.0,32.0,503.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC389190,SRAS,Section 5,SC62,Radiology,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,2880.0,2880.0,31.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,195840.0,1437.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,243.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,53280.0,86.0,503.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,25920.0,14.0,503.0
"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,regular,AC415100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,20160.0,20160.0,5.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,1440.0,195840.0,1450.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,257.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,53280.0,87.0,503.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,1440.0,25920.0,15.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,1440.0,113760.0,258.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,1440.0,53280.0,88.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,DRAD,Section 5,SC62,Radiology,1.0,2007-02-01 23:00:00,1380.0,2.0,3.0,23.0,0.0,113760.0,256.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1456.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1467.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1468.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1469.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1452.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1453.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1454.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,260.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1455.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,261.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1457.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1458.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,262.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1459.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1460.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1461.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1462.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1463.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,263.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1464.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1465.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,264.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1466.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1470.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1471.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1472.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,265.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,197280.0,1451.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,259.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,54720.0,89.0,503.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,27360.0,16.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,1440.0,197280.0,1473.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,115200.0,266.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,0.0,54720.0,90.0,503.0
Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787800,59.0,885,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,1440.0,27360.0,17.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,1440.0,115200.0,267.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-02 23:00:00,1380.0,2.0,4.0,23.0,1440.0,54720.0,91.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1478.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1485.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1486.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1475.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1476.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,269.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,270.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,271.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1477.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,272.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1479.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,273.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1480.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1481.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1482.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,274.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1483.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,275.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1484.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,276.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1487.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,277.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,278.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,198720.0,1474.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,268.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,56160.0,92.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,1440.0,198720.0,1488.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,116640.0,279.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,0.0,56160.0,93.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,1440.0,116640.0,280.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-03 23:00:00,1380.0,2.0,5.0,23.0,1440.0,56160.0,94.0,503.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,5.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,289.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,8.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,13.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,14.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,15.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,296.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,297.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,298.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,299.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,300.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,301.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,304.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,18.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,305.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,19.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,306.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,307.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,21.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,22.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,23.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,24.0,504.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,306720.0,159.0,504.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,306720.0,160.0,504.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,306720.0,161.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,282.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,283.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,284.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,285.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,286.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,1.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,2.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,3.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,4.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,6.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,287.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,288.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,7.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,290.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,291.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,9.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,10.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,292.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,293.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,11.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,294.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,295.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,12.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,302.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,16.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,303.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,17.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,20.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,308.0,504.0
Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,25.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,309.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,310.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC380000,SRA1,Section 5,SC62,Radiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,311.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,312.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,200160.0,1491.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,200160.0,1492.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,200160.0,1489.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,200160.0,1490.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,120960.0,149.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,120960.0,150.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,281.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,57600.0,95.0,504.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC410500,SGVE,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,145.0,504.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,96480.0,306720.0,162.0,504.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC411100,SGVS,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,12960.0,30240.0,146.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,120960.0,151.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,1440.0,200160.0,1493.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,8640.0,120960.0,152.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,118080.0,313.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,57600.0,96.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,1440.0,118080.0,314.0,504.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,1440.0,57600.0,97.0,504.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,other,SGVE,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-04 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,144.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,122400.0,154.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,585.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,586.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1498.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,591.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,592.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,593.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,594.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1503.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,595.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1504.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,597.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,598.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1505.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1506.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,11520.0,35.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,11520.0,36.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,11520.0,37.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,582.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,583.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1495.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1496.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,584.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1497.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,587.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1499.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1500.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,588.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,589.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1501.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,590.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1502.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,596.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,599.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1507.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,338400.0,600.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1508.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,122400.0,155.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,122400.0,156.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,122400.0,157.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1494.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,122400.0,153.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,119520.0,315.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,59040.0,98.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,11520.0,33.0,503.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,97920.0,338400.0,601.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,201600.0,1509.0,503.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,1440.0,122400.0,158.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,119520.0,316.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,59040.0,99.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,1440.0,119520.0,317.0,503.0
Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,1440.0,59040.0,100.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC619600,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,5760.0,11520.0,38.0,503.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,1440.0,201600.0,1510.0,503.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,other,OKU1,Section 3,SC7,Operating rooms,1.0,2007-02-05 23:00:00,1380.0,2.0,0.0,23.0,0.0,11520.0,34.0,503.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,342.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,343.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,344.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,345.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,346.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,337.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,338.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,339.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,340.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,341.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,367.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,368.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,369.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,370.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,371.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,379.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,380.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,381.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,382.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,383.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,384.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,385.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,386.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,387.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,388.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,389.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,386001Z,DRAD,Section 5,SC62,Radiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,404.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC356132,LVPT,Section 4,SC88,Pathology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,320.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,321.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,322.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,323.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,324.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,325.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,326.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,327.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,328.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,329.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,330.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,331.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,332.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,333.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,334.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,335.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,336.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,347.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,348.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,349.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,350.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,351.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,352.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,353.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,354.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,355.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,356.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,357.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,358.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,359.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,360.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,361.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,362.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,363.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,364.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,365.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,366.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,372.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,373.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,374.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,375.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,376.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,377.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,378.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,390.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,391.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,392.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,393.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,394.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,395.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,396.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,397.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,398.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,399.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,400.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,401.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,402.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,403.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,203040.0,1511.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,123840.0,159.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,318.0,504.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,504.0
Plav.celcarc. vulva: st II,TC613,M11,SC7,DTC527942,79.0,784,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,87840.0,282240.0,103.0,504.0
Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,20160.0,241920.0,321.0,504.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,1440.0,203040.0,1512.0,504.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,1440.0,123840.0,160.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H1NO,Section 3,SC7,Recovery room / high care,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,405.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H1NO,Section 3,SC7,Recovery room / high care,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,406.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,1440.0,120960.0,407.0,504.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,other,LVPT,Section 4,SC88,Pathology,1.0,2007-02-06 23:00:00,1380.0,2.0,1.0,23.0,0.0,120960.0,319.0,504.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1516.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,417.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,418.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,150.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,415.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,416.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1522.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1523.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,372454A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,152.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,429.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,430.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1524.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,431.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,432.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1525.0,500.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898,regular,387042A,SRAS,Section 5,SC62,Radiology,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,1440.0,3.0,500.0
Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898,regular,387042A,SRAS,Section 5,SC62,Radiology,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,1440.0,1440.0,4.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1514.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1515.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,409.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,410.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,411.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,147.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,148.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,412.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,413.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,414.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,149.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1517.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1518.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,419.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,420.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,421.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,422.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1519.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,423.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,424.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1520.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,425.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,426.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1521.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,151.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,427.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,428.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,433.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,434.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC378808,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,153.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1526.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1527.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,435.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,436.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,1440.0,122400.0,437.0,500.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,4320.0,34560.0,154.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,204480.0,1513.0,500.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,125280.0,161.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H1NO,Section 3,SC7,Recovery room / high care,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,0.0,122400.0,408.0,500.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,70560.0,256320.0,26.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,1440.0,204480.0,1528.0,500.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-07 23:00:00,1380.0,2.0,2.0,23.0,1440.0,125280.0,162.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-08 23:00:00,1380.0,2.0,3.0,23.0,0.0,205920.0,1529.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-08 23:00:00,1380.0,2.0,3.0,23.0,0.0,123840.0,438.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-08 23:00:00,1380.0,2.0,3.0,23.0,1440.0,205920.0,1530.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-08 23:00:00,1380.0,2.0,3.0,23.0,0.0,123840.0,439.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-08 23:00:00,1380.0,2.0,3.0,23.0,1440.0,123840.0,440.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-09 23:00:00,1380.0,2.0,4.0,23.0,0.0,207360.0,1531.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-09 23:00:00,1380.0,2.0,4.0,23.0,0.0,125280.0,441.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-09 23:00:00,1380.0,2.0,4.0,23.0,1440.0,207360.0,1532.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-09 23:00:00,1380.0,2.0,4.0,23.0,0.0,125280.0,442.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-09 23:00:00,1380.0,2.0,4.0,23.0,1440.0,125280.0,443.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,448.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,451.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,456.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,457.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,458.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,460.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,461.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,463.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,464.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,445.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,446.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,447.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,449.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,450.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,452.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,453.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,454.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,455.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,459.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,462.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,465.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,466.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,208800.0,1533.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,444.0,500.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,1440.0,208800.0,1534.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,0.0,126720.0,467.0,500.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-10 23:00:00,1380.0,2.0,5.0,23.0,1440.0,126720.0,468.0,500.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,6.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1540.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,165.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,472.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,9.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,14.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1546.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,15.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,16.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1547.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1548.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1549.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1551.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,170.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,477.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,19.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1552.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,171.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,478.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,20.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1554.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,22.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1555.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,23.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1556.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,24.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1557.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,25.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,1.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1536.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1537.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1538.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1539.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,163.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,164.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,470.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,471.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,2.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,3.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,4.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,5.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,7.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,8.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1541.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,166.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,473.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,10.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1542.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1543.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,11.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1544.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,167.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,474.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,12.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1545.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,168.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,475.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,13.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,17.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,18.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1550.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,169.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,476.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1553.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,21.0,499.0
"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,26.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC378858,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1558.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1559.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1560.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,131040.0,172.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,479.0,499.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC388170,SRA4,Section 5,SC62,Radiology,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,28800.0,84960.0,145.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1535.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,469.0,499.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,40320.0,141120.0,178.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,5760.0,131040.0,173.0,499.0
Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,74880.0,120960.0,49.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,210240.0,1561.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,0.0,128160.0,480.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,1440.0,128160.0,481.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-02-11 23:00:00,1380.0,2.0,6.0,23.0,1440.0,210240.0,1562.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,177.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,175.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,176.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,178.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,179.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,180.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC375075,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,181.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,182.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,183.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,211680.0,1563.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,174.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,129600.0,482.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,184.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,211680.0,1564.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,185.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,129600.0,483.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,1440.0,129600.0,484.0,499.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC709999,BOXD,Section 1,SC99,Diet Studies,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,1440.0,211680.0,1565.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,0.0,132480.0,186.0,499.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC710170,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 23:00:00,1380.0,2.0,0.0,23.0,1440.0,132480.0,187.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,33.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,34.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,35.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,5.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,5.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,40.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,8.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,8.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,13.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,13.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,14.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,14.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,15.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,15.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,18.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,18.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,46.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,19.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,19.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,47.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,48.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,21.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,21.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,22.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,23.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,22.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,24.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,23.0,501.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,501.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,36.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,37.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,38.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,3.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,3.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,4.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,4.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,39.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,6.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,6.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,7.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,7.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,41.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,9.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,9.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,10.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,10.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,42.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,11.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,11.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,43.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,12.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,12.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,44.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,16.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,16.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,45.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,17.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,17.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,20.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,20.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,49.0,501.0
"Plaveiselcelca, cervix st IVb",TC113,M13,SC61,DTC694795,74.0,902,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,25.0,501.0
Mucineus adenoca. ovarium st IIIc,TC101,M16,SC7,DTC664986,57.0,903,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,24.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,50.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,51.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,52.0,501.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,213120.0,1566.0,501.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,131040.0,485.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,32.0,501.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,3.0,501.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,501.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,501.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,4.0,501.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,3.0,501.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,4.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,53.0,501.0
Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,1440.0,213120.0,1567.0,501.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,131040.0,486.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,0.0,20160.0,54.0,501.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,1440.0,131040.0,487.0,501.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-13 23:00:00,1380.0,2.0,1.0,23.0,17280.0,20160.0,55.0,501.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,1.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,1.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,2.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,6.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,7.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,5.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,89.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,90.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,91.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,92.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,93.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,94.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,95.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,9.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,10.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,8.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,82.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,83.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,84.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,85.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,86.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,87.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,88.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,14.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,15.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,13.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,15.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,16.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,14.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,16.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,17.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,15.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,19.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,20.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,18.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,20.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,21.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,19.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,124.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,125.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,22.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,23.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,21.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,133.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,134.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,135.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,136.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,137.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,138.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,139.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,140.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,141.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,142.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,143.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,144.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,145.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,146.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,23.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,24.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,22.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,24.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,26.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,23.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC20189,H1NO,Section 3,SC89,Recovery room / high care,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,56.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC337440,OKU1,Section 3,SC7,Operating rooms,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,58.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,59.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,60.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,61.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,62.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,63.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,64.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,65.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,66.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,67.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,68.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,69.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,70.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,71.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,2.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,3.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,4.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,3.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,4.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,5.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,1.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,2.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,3.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,5.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,6.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,4.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,72.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,73.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,74.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,75.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,76.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,77.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,78.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,79.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,80.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,81.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,7.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,8.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,6.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,8.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,9.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,7.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,10.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,11.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,9.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,11.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,12.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,10.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,96.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,97.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,98.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,99.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,100.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,101.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,102.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,103.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,104.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,105.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,106.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,107.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,108.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,109.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,110.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,111.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,112.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,113.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,114.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,115.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,116.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,12.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,13.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,11.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,117.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,118.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,119.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,120.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,121.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,122.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,123.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,13.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,14.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,12.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,17.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,18.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,16.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,18.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,19.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,17.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,126.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,127.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,128.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,129.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,130.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,131.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,132.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,21.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,22.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,20.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC378449,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,25.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,147.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,148.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,149.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,150.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,151.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,152.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,153.0,499.0
Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,25.0,499.0
Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC665732,73.0,905,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,27.0,499.0
Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,0.0,24.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,154.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,155.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,156.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,157.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,158.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,159.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,160.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,161.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,162.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,163.0,499.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC386042,SRAS,Section 5,SC62,Radiology,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,1440.0,6.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,132480.0,488.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,57.0,499.0
Plaveiselcelca. vagina st III,TC101,M12,SC61,DTC785647,82.0,791,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,44640.0,282240.0,57.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,132480.0,489.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H1NO,Section 3,SC7,Recovery room / high care,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,21600.0,164.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,1440.0,132480.0,490.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H1NO,Section 3,SC7,Recovery room / high care,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,1440.0,21600.0,165.0,499.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,other,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,0.0,1440.0,5.0,499.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,other,SRAS,Section 5,SC62,Radiology,1.0,2007-02-14 23:00:00,1380.0,2.0,2.0,23.0,1440.0,1440.0,7.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,180.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,181.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,182.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,183.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,176.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,177.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,178.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,179.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737C,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,200.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,201.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,206.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,207.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,208.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,376482C,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,209.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,210.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,211.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,212.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,377498A,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,213.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,167.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,168.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,169.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,170.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,171.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,172.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,173.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,174.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370402,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,175.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,184.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,185.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,186.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370424,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,187.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,188.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,189.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,190.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370440,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,191.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,192.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,193.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,194.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,195.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,196.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,197.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,198.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,199.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,202.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,203.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,204.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC372414,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,205.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,214.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,215.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,216.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378458,CRLE,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,217.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,218.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,219.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,220.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,221.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,222.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,133920.0,491.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,166.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,133920.0,492.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,0.0,23040.0,223.0,499.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,1440.0,133920.0,493.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-15 23:00:00,1380.0,2.0,3.0,23.0,1440.0,23040.0,224.0,499.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,228.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,226.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,227.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,229.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,230.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,231.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,232.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,135360.0,494.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,225.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,135360.0,495.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,0.0,24480.0,233.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,1440.0,135360.0,496.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-16 23:00:00,1380.0,2.0,4.0,23.0,1440.0,24480.0,234.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,0.0,136800.0,497.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,0.0,25920.0,235.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,0.0,136800.0,498.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,0.0,25920.0,236.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,1440.0,136800.0,499.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-17 23:00:00,1380.0,2.0,5.0,23.0,1440.0,25920.0,237.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,302211.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,40.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,302213E,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,41.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,302282.0,NGIV,Section 5,SC63,Nuclear Medicine,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,42.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,5.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,190.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,45.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,8.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,13.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,14.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,15.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,195.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,18.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,196.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,19.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,197.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,21.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,22.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,23.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,188.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,189.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,43.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,44.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,1.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,2.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,3.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,4.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,6.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,7.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,191.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,9.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,10.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,192.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,11.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,193.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,12.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,46.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,16.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,47.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,17.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,194.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,20.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,48.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,24.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,141120.0,198.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,49.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,25.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,26.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,27.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,138240.0,500.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,39.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,27360.0,238.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,28.0,498.0
"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851,regular,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,8640.0,141120.0,199.0,498.0
"Plaveiselcelca, cervix st Ia1",TC503,M13,SC7,DTC667327,37.0,907,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,29.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC610001,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,50.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,138240.0,501.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,30240.0,51.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,0.0,27360.0,239.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,1440.0,138240.0,502.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,18720.0,30240.0,52.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-18 23:00:00,1380.0,2.0,6.0,23.0,1440.0,27360.0,240.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,12.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,506.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,15.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,20.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,21.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,22.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,511.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,24.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,512.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,25.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,28800.0,243.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,27.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC337440,OKU1,Section 3,SC7,Operating rooms,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,31680.0,54.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,31680.0,55.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC356133,LVPT,Section 4,SC88,Pathology,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,31680.0,56.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,504.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,505.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,28800.0,242.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,10.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,11.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,13.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,14.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,507.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,16.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,17.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,508.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,18.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,509.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,19.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,510.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC370711,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,23.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,26.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC378729,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,28.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,513.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,28800.0,244.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,29.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,503.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,31680.0,53.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,28800.0,241.0,498.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,AC411100,SGVS,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,17280.0,51840.0,156.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,7200.0,8640.0,30.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,139680.0,514.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,31680.0,57.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,28800.0,245.0,498.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,1440.0,139680.0,515.0,498.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,1440.0,31680.0,58.0,498.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,1440.0,28800.0,246.0,498.0
Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,deviant,other,SGVE,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,51840.0,155.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,other,other,Section 1,other,other,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,8.0,498.0
Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,regular,other,other,Section 1,other,other,1.0,2007-02-19 23:00:00,1380.0,2.0,0.0,23.0,0.0,8640.0,9.0,498.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,5.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,10.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,13.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,18.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,19.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,20.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,23.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,24.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,26.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,27.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,6.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,7.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,8.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,9.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,11.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,12.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,14.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,15.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,16.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,17.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,21.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,22.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,25.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,28.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,29.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,10080.0,30.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,141120.0,516.0,496.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,33120.0,59.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,30240.0,247.0,496.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,10080.0,10080.0,31.0,496.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,12960.0,97920.0,146.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,141120.0,517.0,496.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,33120.0,60.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,0.0,30240.0,248.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,1440.0,141120.0,518.0,496.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,1440.0,33120.0,61.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-20 23:00:00,1380.0,2.0,1.0,23.0,1440.0,30240.0,249.0,496.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,64.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,521.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,63.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,522.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,523.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,65.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,519.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,520.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,62.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,31680.0,250.0,495.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,262080.0,372960.0,113.0,495.0
Gynaecologische tumoren,TC61,DC106,SC7,DTC594740,53.0,797,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,20160.0,276480.0,27.0,495.0
Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,regular,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,23040.0,361440.0,602.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,142560.0,524.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,34560.0,66.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,0.0,31680.0,251.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,1440.0,142560.0,525.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,1440.0,34560.0,67.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-21 23:00:00,1380.0,2.0,2.0,23.0,1440.0,31680.0,252.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,339099B,OKU1,Section 3,SC61,Operating rooms,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,527.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,6.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,9.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,14.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,15.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,16.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,19.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,20.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,33120.0,255.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,22.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,23.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,24.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,1.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,33120.0,254.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,2.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,3.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,4.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,5.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,7.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,8.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,10.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,11.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,12.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,13.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,17.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,18.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,21.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,25.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,33120.0,256.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,26.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,27.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390183,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,528.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390520,SRA5,Section 5,SC62,Radiology,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,529.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,530.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,526.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,36000.0,68.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,33120.0,253.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,28.0,495.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,0.0,29.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,144000.0,531.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,36000.0,69.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,0.0,33120.0,257.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,1440.0,144000.0,532.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,1440.0,36000.0,70.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-22 23:00:00,1380.0,2.0,3.0,23.0,1440.0,33120.0,258.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370501.0,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,263.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,264.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,265.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,266.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370505A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,267.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,268.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,375138A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,269.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,535.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,260.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,261.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,262.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,536.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,537.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,538.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,270.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,539.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,271.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,533.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,F5NO,Section 1,SC61,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,534.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,37440.0,71.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,259.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,145440.0,540.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,37440.0,72.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,0.0,34560.0,272.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,1440.0,145440.0,541.0,495.0
Plav.celcarc. vulva: (st onbekend),TC803,M11,SC7,DTC654372,46.0,892,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,1440.0,37440.0,73.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-23 23:00:00,1380.0,2.0,4.0,23.0,1440.0,34560.0,273.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,0.0,146880.0,542.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,0.0,36000.0,274.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,0.0,146880.0,543.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,0.0,36000.0,275.0,495.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,1440.0,146880.0,544.0,495.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-24 23:00:00,1380.0,2.0,5.0,23.0,1440.0,36000.0,276.0,495.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,5.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,548.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,8.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,13.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,14.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,15.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,553.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,18.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,554.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,19.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,370737Z,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,37440.0,279.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,21.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,22.0,496.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,4320.0,30.0,496.0
maligniteit cervix,TC803,DC822,SC61,DTC701763,40.0,908,regular,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,4320.0,4320.0,31.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,546.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,547.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,37440.0,278.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,1.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,2.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,3.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,4.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,6.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,7.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,549.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,9.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,10.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,550.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,11.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,551.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,12.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,16.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,17.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,552.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,20.0,496.0
Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,0.0,23.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,555.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,37440.0,280.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,545.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,37440.0,277.0,496.0
"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856,regular,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,57600.0,141120.0,161.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,148320.0,556.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,0.0,37440.0,281.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,1440.0,148320.0,557.0,496.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-25 23:00:00,1380.0,2.0,6.0,23.0,1440.0,37440.0,282.0,496.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,5.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,149760.0,560.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,8.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,13.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,14.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,15.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,18.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,19.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,21.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,22.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,23.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,24.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,149760.0,559.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,1.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,2.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,3.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,4.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,6.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,7.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,9.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,10.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,11.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,12.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,16.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,17.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,20.0,497.0
maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,0.0,25.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,149760.0,561.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,149760.0,558.0,497.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,38880.0,283.0,497.0
Gynaecologische tumoren,TC13,DC106,SC61,DTC786315,72.0,900,regular,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,8640.0,18720.0,32.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,149760.0,562.0,497.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,0.0,38880.0,284.0,497.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,1440.0,149760.0,563.0,497.0
Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-26 23:00:00,1380.0,2.0,0.0,23.0,1440.0,38880.0,285.0,497.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370136A,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,12.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,13.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,16.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,26.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,27.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,28.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,34.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,35.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,39.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,376482C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,40.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,377498A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,41.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,44.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,2.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,3.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,4.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,5.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,6.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,7.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,8.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370111,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,9.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370129,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,10.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370135,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,11.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,14.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,15.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370415,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,17.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,18.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370420,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,19.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370421,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,20.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,21.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370424,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,22.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370424,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,23.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,24.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,25.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,29.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,30.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,31.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,32.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,33.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC372414,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,37.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,38.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC378149,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,42.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC378452,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,43.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC378458,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,45.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,46.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,151200.0,564.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,1.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,151200.0,565.0,496.0
"Plaveiselcelca, cervix st IVa",TC113,M13,SC61,DTC621996,74.0,854,regular,AC614400,H5ZU,Section 2,SC7,Nursing ward,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,1440.0,151200.0,566.0,496.0
Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911,deviant,other,URIN,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 23:00:00,1380.0,2.0,1.0,23.0,0.0,0.0,36.0,496.0
